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“I have a friend who’s an artist and has sometimes taken a view which I don’t agree with very well. 
He’ll hold up a flower and say “look how beautiful it is,” and I’ll agree. Then he says “I as an artist can 
see how beautiful this is but you as a scientist take this all apart and it becomes a dull thing,” and I 
think that he’s kind of nutty. First of all, the beauty that he sees is available to other people and to me 
too, I believe… 
I can appreciate the beauty of a flower. At the same time, I see much more about the flower than he 
sees. I could imagine the cells in there, the complicated actions inside, which also have a beauty. I 
mean it’s not just beauty at this dimension, at one centimeter; there’s also beauty at smaller 
dimensions, the inner structure, also the processes. The fact that the colors in the flower evolved in 
order to attract insects to pollinate it is interesting; it means that insects can see the color. It adds a 
question: does this aesthetic sense also exist in the lower forms? Why is it aesthetic? All kinds of 
interesting questions which the science knowledge only adds to the excitement, the mystery and the 
awe of a flower. It only adds. I don’t understand how it subtracts.” 
–Richard Feynman, What Do You Care What Other People Think, 1988 
 
 i 
Acknowledgements 
Most importantly I am very grateful to my supervisor Kiran Patil. Without his enthusiasm and ideas 
this work would not be possible. Kiran always supported and helped me in the hardest and most 
impossible situations. I am also very thankful to him for the opportunity of visiting his group at EMBL 
in Heidelberg. Working at EMBL has opened my view to many different sides of the beautiful world 
of a science. I am thankful to my supervisor Prof. Morten Kielland-Brandt for providing me the 
opportunity to work on my PhD project at the Center for Microbial Biotechnology in Denmark. 
I thank both of my supervisors, DTU and Novozymes for financial support of this work. 
I want to thank all the members of Patil group, colleagues, office mates and friends who made my life 
easier during my PhD time. It is difficult to rank your help and support, so I have chosen to represent 
you alphabetically: Ana Rita Brochado, Ana Paula Oliveira, Anne Nørrevang Johansen, Arnau 
Montagud, Bo Salomonsen, Claudio Alfieri, Joana Xavier, Kalliopi Trachana, Lars Poulsen, Maria 
Secrier, Melanie Schmid, Olga Ponomarova, Pablo Minguez, Sara Lieder, Sergej Andrejev, Takuji 
Yamada, Tomasz Boruta, Tomas Stucko, Veli Vural Uslu, Zita Soons. A special thank goes to Steven 
Sheridan for fighting with my broken English and explicitly commenting on this thesis. 
I am very thankful to my family for their support, patience and understanding... 
 
 iii 
Summary 
Biological systems are characterized by a high degree of complexity wherein the individual 
components (e.g. proteins) are inter-linked in a way that leads to emergent behaviors that are 
difficult to decipher. Uncovering system complexity requires, at least, answers to the following three 
questions: what are the components of the systems, how are the different components 
interconnected and how do these networks perform the functions that make the resulting system 
behavior? Modern analytical technologies allow us to unravel the constituents and interactions 
happening in a given system; however, the third question is the ultimate challenge for systems 
biology. The work of this thesis systematically addresses this question in the context of metabolic 
networks, which are arguably the most well characterized cellular networks in terms of their 
constituting components and interactions among them. Furthermore, there is large interest in 
understanding and manipulating cellular metabolism from health as well as biotechnological 
perspectives. Fundamentally different biological questions are investigated in different core chapters 
of the thesis, though all are linked by the common thread of the functioning of cellular metabolism. 
The three main topics addressed are: i) transcriptional regulation of metabolite concentration, ii) 
transcriptional dys-regulation of skeletal muscle metabolism in type 2 diabetes, and iii) metabolic 
interactions in microbial ecosystems. The overall objective is to obtain novel understanding 
underlying the operating principles of metabolic networks.  
Cellular responses to environmental perturbations and genetic/epigenetic modifications are to a 
large extent controlled through transcription, which is one of the fundamental mechanism/means of 
cellular regulation. An important question is to what extent gene expression can explain metabolic 
phenotype, in other words, how well changes in metabolite concentrations can be explained by the 
changes in related enzyme-coding transcripts? Attempts to predict changes in the metabolome from 
gene expression data have so far remained unsolved. Here, I challenge this question by proposing a 
mechanistic explanation of the interplay between metabolite concentrations, transcripts and fluxes 
based on Michaelis-Menten kinetics at the network-scale. The work demonstrates that in steady-
state systems, changes of intracellular metabolites concentrations are linked with the changes in 
gene expression of both reactions that produce and reactions that consume a given metabolite. 
Analysis of a large compendium of gene expression data further suggested that, contrary to previous 
thinking, transcriptional regulation at metabolic branch points is highly plastic and, in several cases, 
the objective of the regulation appears to be metabolite-oriented as opposed to pathway-oriented. 
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The study thus provides a fundamental and novel view of metabolic network regulation in 
Saccharomyces cerevisiae.  
Metabolism is a conserved system across all domains of life. Nowadays, metabolism has become a 
focal point in diagnosing and treating diseases such as diabetes and cancer. Type 2 diabetes mellitus 
is a complex metabolic disease which is recognized as one of the largest threats to human health in 
the 21st century. Recent studies of gene expression levels in human tissue samples have indicated 
that multiple metabolic pathways are dys-regulated in diabetes and in individuals at risk for diabetes; 
which of these are primary, or central to disease pathogenesis, remains a key question. Cellular 
metabolic networks are highly interconnected and often tightly regulated; any perturbations at a 
single node can thus rapidly diffuse to the rest of the network. Such complexity presents a 
considerable challenge in pinpointing key molecular mechanisms and signatures associated with 
insulin resistance and type 2 diabetes. The present work addresses this problem by using a 
methodology that integrates gene expression data with the human cellular metabolic network. The 
approach is demonstrated by analysis of two skeletal muscle gene expression datasets. The proposed 
methodology identified transcription factors and metabolites that represent potential targets for 
therapeutic agents and future clinical diagnostics for type 2 diabetes and impaired glucose 
metabolism. In a broader context, the study provides a framework for analysis of gene expression 
datasets from complex heterogeneous diseases, genetic, and environmental perturbations that are 
reflected in and/or mediated through changes in metabolism. 
In nature, microorganisms do not exist as pure cultures, but evolve and co-exist with other species. 
Microbial communities have a variety of potential applications, including metabolic disease therapies 
and biotechnology. For example, microbial consortia consisting of various bacteria and fungi are 
known to exhibit a biodegradation performance superior to pure cultures, making them attractive 
research targets. It is believed that nutrition plays a crucial role in shaping microbial communities. 
Interspecies metabolite cross-feeding can confer several advantages to the community as a whole. 
For example, more efficient and complete use of available nutrients, or increased ability to survive 
under diverse/changing nutrition availability potentially induces fitness of individuals. The third topic 
of this thesis investigates the role of metabolic interaction in co-occurring microbial communities. 
The study aims to identify metabolic properties that shape the community structures. The analysis 
based on a global metagenomic dataset and genome-scale metabolic models suggested that species 
within coexisting communities have higher potential of metabolic cooperation compared to random 
controls. This work yielded a novel methodology (termed species metabolic coupling analysis) for 
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studying metabolic interaction and interdependencies within microbial communities. Species 
metabolic coupling analysis has a spectrum of applications to real-world problems, including 
investigation of metabolic interactions within the human microbiome, host-pathogen interactions 
and development of stable microbial communities.  
Overall, this work contributes with novel insights, tools and methodologies to study the operation of 
cellular metabolism. 
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Dansk Sammenfatning 
Biologiske systemer er karakteriseret ved en høj grad af kompleksitet, hvori de individuelle 
komponenter (f.eks. proteiner) er indbyrdes forbundet på en måde, der fører til en opførsel, der er 
vanskelig at forstå i detaljer. Udredning af systemets kompleksitet kræver i det mindste svar på 
følgende tre spørgsmål: hvad er komponenterne af systemerne, hvordan er de forskellige 
komponenter sammenkoblet, og hvordan udfører disse netværk de funktioner, der resulterer i 
systemernes adfærd? Moderne analytiske teknologier giver os mulighed for at optrævle de 
bestanddele og interaktioner der findes i et givet system, men det tredje spørgsmål er den ultimative 
udfordring for systembiologi. Nærværende afhandling behandler dette spørgsmål systematisk i 
forbindelse med metaboliske netværk, som velsagtens er de mest velbeskrevne biologiske netværk 
hvad angår komponenter og samspillet mellem dem. Desuden er der stor interesse for at forstå og 
manipulere cellestofskiftet ud fra såvel sundhedsmæssige som bioteknologiske perspektiver. 
Fundamentalt forskellige biologiske spørgsmål undersøges i forskellige centrale kapitler i 
afhandlingen, selv om de alle er forbundet af det fælles tema omkring, hvordan det cellulære 
stofskifte fungerer. De tre vigtigste emner, der behandles, er: i) Transkriptionel regulering af 
metabolit-koncentrationer, ii) transkriptionel dys-regulering af skeletmuskulaturens stofskifte i type-
2 diabetes, og iii) metaboliske interaktioner i mikrobielle økosystemer. Det overordnede mål er at 
opnå ny forståelse bag de operationelle principper for metaboliske netværk. 
Cellers reaktioner på forstyrrelser i vækstvilkår og genetiske/epigenetiske ændringer styres i høj grad 
gennem transkription, som er en af de grundlæggende mekanismer for cellulær regulering. Et vigtigt 
spørgsmål er, i hvilket omfang genekspression kan forklare metaboliske fænotyper; med andre ord, 
hvor godt kan ændringer i metabolitkoncentrationer forklares med ændringer i mængderne af mRNA 
kodende for de ansvarlige enzymer? Forsøg på at forudsige ændringer i metabolomet ud fra 
genekspressionsdata har hidtil ikke ladet sig gøre. Her udfordrer jeg dette spørgsmål ved at foreslå 
en mekanistisk forklaring af samspillet mellem metabolitkoncentrationer, transkripter og flux baseret 
på Michaelis-Menten kinetik på netværks-skala. Dette arbejde viser, at i steady-state systemer er 
ændringer i intracellulære metabolit-koncentrationer forbundet med ændringer i genekspression af 
både reaktioner, der producerer, og reaktioner, der forbruger en bestemt metabolit. I modsætning til 
tidligere tænkning tyder analyse af en stor samling af genekspressionsdata endvidere på, at 
transkriptionel regulering ved metaboliske forgreningspunkter er meget plastisk, og i flere tilfælde 
synes den selektive fordel ved reguleringen at være metabolit-orienteret snarere end pathway-
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orienteret. Undersøgelsen giver således et fundamentalt og nyt syn på metabolisk 
netværksregulering i Saccharomyces cerevisiae. 
Metabolisme er et i høj grad bevaret system på tværs af hele biologien. I dag er stofskifte blevet et 
centralt punkt i diagnosticering og behandling af sygdomme såsom diabetes og kræft. Type 2-
diabetes mellitus er en kompleks metabolisk sygdom, der er anerkendt som en af de største trusler 
mod menneskers sundhed i det 21. århundrede. Nylige undersøgelser af genekspressionsniveauer i 
humane vævsprøver har vist, at flere metaboliske veje er dysreguleret i diabetes og hos personer 
med risiko for diabetes; hvilke af disse veje der er primære og/eller centrale for patogenesen, er 
fortsat et centralt spørgsmål. Cellulære metaboliske netværk er meget tæt forbundne og ofte stramt 
regulerede; eventuelle forstyrrelser ved et enkelt forbindelsespunkt kan således hurtigt udbrede sig 
til resten af netværket. En sådan kompleksitet udgør en betydelig udfordring i at indkredse de 
vigtigste molekylære mekanismer og kendetegn, der er forbundet med insulinresistens og type 2 
diabetes. Det foreliggende arbejde løser dette problem ved at bruge en metode, der integrerer 
genekspressionsdata med det humane cellulære metaboliske netværk. Denne fremgangsmåde 
demonstreres ved analyse af to datasæt fra skeletmusklers genekspression. Den foreslåede metode 
identificerede transkriptionsfaktorer og metabolitter, der udgør potentielle mål for farmaka og 
fremtidig klinisk diagnose for type 2-diabetes og forringet glukosemetabolisme. I en bredere 
sammenhæng frembyder undersøgelsen en ramme for analyse af genekspression-data indsamlet ved 
komplekse heterogene sygdomme, genetiske og miljømæssige perturbationer, der afspejles i og/eller 
er medieret via ændringer i stofskiftet. 
I naturen eksisterer mikroorganismer normalt ikke som rene kulturer, men udvikler sig og 
sameksisterer med andre arter. Mikrobielle samfund har en bred vifte af mulige anvendelser, 
herunder behandling af metaboliske sygdomme og bioteknologi. Eksempelvis kan mikrobielle 
konsortier bestående af forskellige bakterier og svampe udføre biologisk nedbrydning bedre end 
rene kulturer, hvilket gør dem attraktive at udforske. Det er almindeligt antaget, at ernæring spiller 
en afgørende rolle i udformningen af mikrobielle samfund, og indbyrdes udveksling og udnyttelse af 
metabolitter kan give flere fordele for samfundet som helhed. For eksempel kan en mere effektiv og 
fuldstændig anvendelse af de tilgængelige næringsstoffer, eller en forbedret evne til at tilpasse sig 
skiftende ernæringsforhold, føre til forbedret overlevelse af individerne. Det tredje emne i denne 
afhandling undersøger de metaboliske interaktioners rolle i blandede mikrobielle samfund. Formålet 
med undersøgelsen er at identificere de egenskaber ved metabolismen, der er bestemmende for 
strukturerne af de blandede samfund. Analysen er baseret på et globalt metagenomisk datasæt, og 
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metaboliske modeller i genom-skala pegede på, at arter inden for sameksisterende samfund har et 
større potentiale for metabolisk samarbejde i forhold til tilfældigt sammensatte samfund. Dette 
arbejde førte til en ny metode (kaldet species metabolic coupling analysis) for at studere metabolisk 
interaktion og indbyrdes afhængighed inden for mikrobielle samfund. Metoden har en vifte af 
konkrete anvendelser, herunder undersøgelse af metaboliske interaktioner i menneskets mikrobiom, 
værtspatogene interaktioner og udvikling af stabile mikrobielle samfund. 
Samlet set bidrager dette arbejde med nye indsigter, værktøjer og metoder til at studere hvordan 
cellulært stofskifte fungerer. 
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Chapter 1  
Introduction and work objectives 
Modern analytical technologies generate larger and larger ‘omics’ data sets across all branches of life 
sciences. The revolution in large-scale data generation continues to drive advances in modern 
biology, leading to conceptual developments and novel discoveries. However, current technologies 
focus on generating data, or, in other words assessing the concentrations of components but not 
their functions in biological systems (Sauer & Zamboni, 2008). Biological systems are extremely 
complex by their nature. A prerequisite for attaining understanding of any system is the knowledge 
of its constituent components and, most important, the interactions between those components. 
One the greatest challenge of modern biology is to transform the massive amounts of generated 
data into the biological knowledge. Therefore, for understanding underlying biological phenomena 
there is a general need to develop new approaches and tools that are capable of using multi-level 
large scale biological data for extraction of relevant biological signal. In particular, it is essential to 
identify linkages and mechanisms which underlie the logic of cellular organization and bring together 
interactions and structural components making a functional core of a cellular system. Metabolism is 
the fundamental basis of life at all scales, from the enzymatic reactions happening in each cell all the 
way to the multicellular organisms and the ecosystem as a whole. The research of this thesis is 
focused on i) identification the principles behind the regulation and operation of cellular metabolic 
network in model eukaryote Saccharomyces cerevisiae, ii) application of systems level analysis to 
human metabolic network in context of perturbed networks, iii) and illustrate the critical role of 
metabolism in microbial ecosystems. 
The study of biochemical reactions and metabolism has been at the center of biological research 
since the nineteenth century (Fraenkel, 2011). However, in past 30 years under the shadow of 
advances in the field of molecular biology (McKnight, 2010) some scientists treated metabolism as a 
field ‘to be mastered and put aside’ (Bar-Even et al, 2012; Ray, 2010). Nevertheless, in recent years, 
the scientific community witnessed a rebirth in metabolic research as its part has been recognized 
playing a crucial role in many real-world applications (Bar-Even et al, 2012; Heinemann & Sauer, 
2010; Klitgord & Segre, 2011; Reaves & Rabinowitz, 2011) For example, metabolism research has 
become crucial in diagnosing and treating diseases such as type 2 diabetes and cancer (Muoio & 
Newgard, 2008; Vander Heiden, 2011). Also, much of today’s research is focused on addressing 
emerging challenges in sustainable energy, environmental chemistry and pharmaceutical industry by 
“squeezing” metabolism of microbial cell factories in the most needed way (Bar-Even et al, 2012). To 
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study, manipulate and redesign a metabolic system, one has to have a solid understanding of the 
biochemical and regulatory principles governing it. 
In contrast to other biological networks, the functions and structure of metabolism are well 
understood (Gerosa & Sauer, 2011). Analytical techniques for quantitative measurements of 
metabolism components (metabolites, enzymes, fluxes) are available (Sauer & Zamboni, 2008). The 
current progress in systems level understanding of cellular metabolism was recently reviewed by 
Sauer and colleagues (Gerosa & Sauer, 2011; Heinemann & Sauer, 2010). Despite all the recent 
advances of analytical techniques, what we are still lacking is the knowledge of principles of 
regulatory networks that control metabolism functioning. Generally, we are missing the true system 
understanding of metabolism regulation in the complex genotype-to-phenotype path. For example, 
often it is unknown how metabolite concentration emerges from the interactions in the underlying 
network (Gerosa & Sauer, 2011); in other words, it is not clear how cells control metabolite pools in 
response to changing nutrient availability. Therefore, one of the objectives of the present work was 
to investigate possible quantitative mechanisms underlying regulation of metabolite concentration. 
Chapter 3 and Chapter 4 describe fundamentally different approach looking at the metabolite 
regulation. The presented integrative method provides novel quantitative mechanistic insights of 
transcriptional regulation of Saccharomyces cerevisiae metabolism. 
Detailed molecular data obtained from studies of biological systems also change our view on 
pathogenesis of human diseases (del Sol et al, 2010). Despite the current progress in disease gene 
discovery, we are lacking mechanistic understanding of cellular diseases. Even many heritable 
diseases cannot be explained by classic one-to-one genotype-phenotype models (Wang et al, 2011). 
A widely accepted theory (Barabasi et al, 2011; del Sol et al, 2010; Emmert-Streib & Dehmer, 2011) is 
that diseases result from perturbation of cellular networks. One of the best examples is type 2 
diabetes (T2DM), which is considered as disease of 21st century having an enormous health and 
economic impact in many countries all over the world. Currently 347 million people worldwide 
diagnosed with diabetes, and this number is expected to increase by 60% by 2030 (WHO, 2012). This 
fact sparked my interest studying the metabolism of T2DM; in particular, I focused on elucidating 
metabolic regulation signatures in connection with T2DM to provide novel insights about the 
pathogenesis of disease and discover possible biomarkers of disease progression. Chapter 5 
demonstrates an example and potential of integrative methods for studying complex metabolic 
diseases. The proposed framework can be applied not only to finding molecular signatures in disease 
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related perturbations, but also to investigating the regulation of metabolic networks in microbes 
following genetic or environmental perturbations. 
In nature, very few species exist in isolation; nearly all life forms are in some way interacting between 
each other. For example, microorganisms do not exist as pure isolated cultures, but usually form 
complex ecological interaction webs – ecosystems. Microorganisms have a large impact on our daily 
lives – they produce dairy products (Chen et al, 2009), are part of our immune system (Phelan et al, 
2012), play important role in digestion (Arumugam et al, 2011), and clean our waste and pollution 
(Mikeskova et al, 2012). In equilibrium, microorganisms coexist in the stable communities and 
perturbation of these communities can have a catastrophic impact on our society, e.g. epidemics 
(Phelan et al, 2012). Interactions within these communities can have a positive impact, a negative 
impact or no effect on the individuals involved. All of these interactions, regardless their outcome 
happens through a diverse set of mechanisms by which molecular information (including DNA and 
proteins) is being exchanged (Phelan et al, 2012). Microbial communities are very diverse in their 
structures (Fuhrman, 2009), and it is not clear what types of interactions are most prevalent. There is 
a common believe that nutrition is a driving force that shapes microbial communities (Fuhrman, 
2009). By cross-feeding each other, community as a group possibly could survive in more conditions 
and thus potentially induce fitness of individuals. However, due to technical limitations it is 
particularly challenging to probe interactions within a community, for example, determine which 
metabolites are being exchanged and what exactly is the role of these interactions in shaping 
communities. One way to tackle this problem is to model metabolic capabilities of individual 
members within a group of species. Chapter 6 describes a method which was developed to model 
metabolic interactions between species of large size communities and provides an example of 
community metabolic modeling in co-occurring species derived from global environmental data. 
Outline of thesis 
The work presented in this thesis spans fundamentally different problems which are united by the 
common thread of functioning of metabolic networks with the overall objective of gaining novel 
understanding behind the operating principles of microbial metabolism. The thesis is organized in 
several chapters, starting from basic principles about the organization of cellular metabolism, and 
the following four chapters representing different biological applications. Each chapter introduces 
the reader to the biological problem, provides its own results, the discussion and methods sections 
and can be read independently. Readers familiar with the topic of metabolic networks may skip 0; 
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however, before reading Chapter 4 it is recommended that the reader have an understanding of the 
mechanistic principles described in Chapter 3. The work is concluded with summary and future 
directions (Chapter 7). An outline of the thesis is presented in Table 1.1 
Table 1.1 Organization of the present work 
General background 
Chapter 2 
 
Introduction to metabolism and key properties of 
metabolic networks 
Regulation of metabolic networks 
Chapter 3, Chapter 4 
 
Novel mechanistic view about regulation of metabolite 
concentrations in Saccharomyces cerevisiae 
Application of data integrative methods 
Chapter 5 
 
An example of integrative systems analysis for studying 
metabolism related diseases, type 2 diabetes case study 
Modeling metabolic interaction in  
microbial communities 
Chapter 6 
 
 
New stoichiometric method for modeling metabolic 
interactions in microbial communities. Illustrates the 
role of metabolism in microbial coexistence 
Conclusions and future perspectives 
Chapter 7 
 
 
Summarizes the work and suggest the future directions 
in the analysis of biological systems 
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Chapter 2  
General background 
Organization of cellular metabolism/metabolic networks 
Metabolism can be described as a biological system which a cell acquires to fulfill its requirements by 
synthesizing the cellular components and energy needed for growth and maintenance. One of the 
most important challenges in modern biology is to understand the relationship between structure, 
function, and regulation of complex biological networks including metabolism. The biochemical 
transformations of metabolism are well studied and documented (Cherry et al, 2012; Joshi-Tope et 
al, 2003; Kanehisa, 2002; Kumar et al, 2012; Schellenberger et al, 2010) providing the basis for 
building large-scale, structurally accurate biological networks.  
Conventionally, metabolism has been described and viewed as a set of discrete pathways. Pathways 
consist of sets of enzymes operating towards synthesis/degradation of certain metabolites or a group 
of metabolites. Although the concept of a pathway is widely used and is particularly useful for 
illustrative purposes (Figure 2.1), it has become increasingly clear that metabolism operates as a 
highly integrated network (Sweetlove et al, 2008). The definition of a pathway is not exact from the 
stoichiometric point of view. For example, synthesis of one metabolite often involves the operation 
of many pathways requiring energy and cofactors (i.e. NADH/CoA/ATP) which must be available to 
drive the reaction. The biochemical makeup of enzymes and metabolites varies between organisms, 
but in terms of stoichiometrically balanced reaction sets, the general picture of metabolism is similar 
across many organisms. The global overview of cellular metabolic pathways is depicted in Figure 2.1. 
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Figure 2.1 Global overview of metabolic pathways. Metabolism is arbitrarily divided into 11 parts according to the chemical type of compounds. Figure source: http://pathways.embl.de 
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In the post-genomic era, biological systems are viewed as networks which are often represented as 
graphs (Eisenberg et al, 2000). Particularly, for metabolic pathways, enzymes and metabolites are 
represented as nodes and interaction between them as edges. Edges can be directional or 
bidirectional. A metabolite node interacts with all of the enzyme nodes that catalyze a reaction 
involving that metabolite, and an enzyme node interacts with all of the metabolites which participate 
in the corresponding reactions. Each node is connected to a different type of node forming a directed 
bipartite graph (Figure 2.2), e.g. metabolite is only connected with enzyme, but two 
metabolites/enzymes cannot be connected together. Although such a representation visually is not 
the most intuitive, from the analytical point of view it provides a direct access to the properties of 
metabolic networks. For example, information such as in how many reactions ATP is being formed or 
which genes/enzymes regulate regulates this process, etc. can be easily accessed. 
 
Figure 2.2 Different representations of metabolic pathways. A) Classical representation of metabolic reactions, highly 
connected metabolites such as ATP are depicted only in individual reactions. B) Same pathway represented as directed 
bipartite graph, where enzymes/metabolites are depicted as nodes and interaction as edges. C) Human metabolic 
reconstruction (Ma et al, 2007) represented as a bipartite graph. Due to metabolism complexity such network 
representation is not very clear for visual inspection. 
Metabolic networks are structurally organized in such a way that a large variety of biochemical 
products and complex macromolecules (such as proteins, DNA, RNA) are synthesized from a 
variability of nutrients by conversion through relatively few common intermediate metabolites. The 
common intermediate metabolites and their enzymes form a hub or the knot of so-called bow-tie 
structure (Csete & Doyle, 2004). This bow-tie structure results in an interconnected core set of 
central reactions that constitute the backbone of high metabolic fluxes. For example, the central 
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carbon metabolism provides a variety of alternative pathways for generating essential precursor 
molecules, energy carrier molecules (ATP) and reduction equivalents (NAD(P)H) (Szallasi et al, 2010). 
Metabolic networks usually are fully connected networks, meaning that it is possible to connect any 
of two nodes in the network (Patil, 2006). Another important property of metabolic networks as of 
many other biological networks is that they exhibit scale-free topology (Wolf et al, 2002). The 
concept of scale-free network (Szallasi et al, 2010) applies to the connectivity distribution of each 
node in the network. Compared with random networks, in which the number of connections is 
highest at the average value and decays exponentially, scale-free networks contain a relatively small 
number of highly connected nodes and distribution of a number of connections in nodes follows a 
power law (Barabasi & Oltvai, 2004). Such topology on a purely structural level exhibits the following 
main properties: i) ‘small-world behavior’ that is any two nodes can be connected via a small number 
of intermediate nodes and ii) probably the most important property of scale-free networks is that 
they are robust in terms of high tolerance to errors. For example, random removal of a large fraction 
of nodes will not destroy a network, which can be observed in gene-knockout studies, deletion of 
certain enzymes (e.g. isoenzymes or enzymes involved in alternative pathways) does not affect the 
growth phenotype (Baba et al, 2006). Moreover, detailed studies of metabolic networks (Albert, 
2005) showed that the power-law connectivity distribution is valid for organisms from all three 
domains of life – bacteria, archaea and eukarya. Metabolite-reaction connectivity distributions of 
several networks used in the present work are depicted in Figure 2.3.  
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Figure 2.3 Metabolite connectivity distributions in metabolic networks. Metabolic networks are scale-free networks which 
are characterized by a power-law connectivity distribution. k represents a number of reactions where a given metabolite is 
involved, and probability P(k), denotes the probability that a selected metabolite has k connections (reactions). Both axes 
are in log 10 scale. Presented metabolic reconstructions (Duarte et al, 2007; Forster et al, 2003) were used in the present 
work. For Escherichia coli, automatic reconstruction from Model SEED pipeline (Henry et al, 2010) is shown. 
Regulation of metabolic fluxes 
As a result of evolution, all living forms developed a fine-tuned system to meet exactly demand for 
energy and building blocks needed for cellular growth and maintenance of biological processes 
(Nielsen, 2003). Before starting to discuss the concepts of metabolic regulation, it is necessary to 
formalize the term “metabolic flux”. Metabolic flux is the amount of substrate utilized (or products 
produced) by a reaction per unit time and usually it is normalized to some measurable parameter 
(for example, gram glucose utilized per hour per gram of cell mass) (Patil, 2006). When cell 
experiences environmental perturbation (changes of nutrients, pH, temperature, osmotic pressure, 
etc), it adjusts its metabolic network to a new steady-state to fit the new environment and this to a 
large extend happens through the sensing of metabolite concentrations. The cell reacts to the 
changes of metabolite concentrations, and, as a result, it sets the system to the new stable steady-
state in order to keep metabolite pools at homeostasis (Figure 2.4). The concentration of a 
metabolite depends on its rate of degradation as well as its rate of synthesis. Moreover, metabolites 
are often synthesized simultaneously rather than in isolation from each other (Stitt et al, 2010).  
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Obviously, such regulation involves a large number of genes, and modifying the activity of the gene 
products (enzymes) influences the fluxes and consequently metabolite concentrations in the 
metabolic network. Metabolites and fluxes are the objects of metabolic regulation and enzymes are 
the tools by which the cell adjusts its metabolic phenotype. Exact biochemical mechanisms that link 
the metabolic network to transcription and translation are not well understood. Adjustments happen 
through the complex pathway of interactions from the sensor molecule action (through specific 
proteins or directly) on genetic information coding sequences (DNA or RNA), down to the functional 
proteins (enzymes) which in turn control metabolic reactions and consequently change metabolic 
phenotype of the cell. 
The fluxes are constrained by the laws of thermodynamics. From the classical Michaelis-Menten 
(Briggs & Haldane, 1925; Michaelis & Menten, 1913) point of view reaction rates/fluxes are 
dependent on three biological quantities interacting at the level of enzyme kinetics: i) presence of 
active enzyme, ii) enzyme properties such as affinity for a substrate or presence of inhibitor and iii) 
metabolite concentrations. The concentration of the metabolite is itself a function of the flux and the 
properties of the enzymes; consequently, there is an enforced/continuous regulation in the system . 
 
Figure 2.4 Metabolism regulation, from gene expression to metabolite levels. A cell experiencing perturbation “senses“ 
metabolite concentration changes, affecting enzyme regulation via potential interactions with proteins and/or mRNA. As a 
regulatory response, metabolite levels are indirectly adjusted to the new stable state (homeostasis) at the genetic level, 
through enzyme abundances. 
Modeling behavior of metabolic networks  
Current sequencing technology is enabling production of thousands of sequenced genomes each 
year which facilitates reconstructions of genome-scale metabolic networks. Over the last few 
decades, there has been developed standards for reconstruction of metabolic networks (Feist et al, 
2009; Thiele & Palsson, 2010), providing the basis for development of automatic metabolic 
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reconstruction platforms (Henry et al, 2010; Karp et al, 2002). Applications, tools and progress of use 
of metabolic network reconstructions have been recently reviewed (Feist et al, 2009; Oberhardt et al, 
2009). 
Apart from structural information, metabolic network reconstructions can be used to model 
intracellular fluxes. A complete mechanistic dynamic model of metabolism would provide the most 
detailed understanding of a biological system and would allow the dynamic prediction of cellular 
behavior. However, measurement of fluxes and metabolite concentrations at the entire metabolic 
network scale is still a difficult task owing to a variety of technological and experimental limitations. 
Moreover, such models require knowledge of reaction mechanisms and in vivo enzyme kinetic 
parameters which are very difficult to obtain making such models applicable only for certain parts of 
the cellular system. On the other hand, a combination of static models with dynamic components has 
been recently successfully applied to model cell cycle of Mycoplasma genitalium, providing a 
outstanding example of understanding dynamic cellular behavior (Karr et al, 2012).  
Another modeling approach that gained community acceptance and popularity over the last decade 
is Flux Balance Analysis (FBA) (Varma & Palsson, 1994). A particular success of the method is that it is 
capable of quantitatively modeling carbon and energy metabolism for the genome-scale networks. 
FBA has been expanded for the variety of applications including finding the best targets for metabolic 
engineering strategies (Brochado et al, 2010; Burgard et al, 2003), large scale integrative modeling by 
combining different levels of information (Karr et al, 2012; Yizhak et al, 2010), microbial community 
models (Freilich et al, 2011; Klitgord & Segre, 2010; Stolyar et al, 2007; Zomorrodi & Maranas, 2012) 
and many more (Burgard et al, 2004; Lewis et al, 2012; Segre et al, 2002). 
Briefly, the fundamental principle behind FBA relies based on conservation of mass. For each 
metabolite (Xi) in the metabolic network a flux balance can be written as:  
)(deg larextracellubiomassradationsynthesis
i VVVV
dt
dX
  
Where V represents fluxes through which the metabolite Xi is synthesized, degraded, used for 
biomass composition and up-taken from or secreted to the extracellular environment. The biomass 
composition and extracellular metabolite uptake/secretion rates are determined experimentally. 
Inside the cell, biochemical transformations happen very rapidly compared to the cellular growth and 
uptake/secretion reactions. Thus the main assumption implies that the reactions are in the (quasi-) 
steady-steady, over a period of time their concentrations remain constant. This makes the fluxes 
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balanced, in other words the formation of metabolite must be balanced by the metabolite 
degradation fluxes in order to not accumulate the intracellular metabolite pool. Typically, the 
solutions to such problems are obtained through the formulation of a linear optimization problem, 
which optimizes a chosen objective function, e.g. the cellular growth. The biological objective of the 
cell has been always under debate (Schuetz et al, 2007; Schuetz et al, 2012); nevertheless, in 
laboratory conditions, the objective of growth has been shown to be in agreement with experimental 
data for some microbial species (Forster et al, 2003; Varma & Palsson, 1994). 
One spectacular application of linear programming applied for metabolic networks is flux coupling 
analysis (Burgard et al, 2004). The methodology allows studying the topology of metabolism 
operation under physiological constraints. Flux coupling analysis is useful method for establishing 
reaction dependencies under given growth conditions.  
Besides the constraint-based methods, another important class of useful techniques for analysis of 
properties and operational principles of metabolic networks is the so-called network-based pathway 
analysis, including elementary modes (Schuster et al, 1999) and extreme pathways (Schilling et al, 
2000). The concept of network-based pathway analysis provides a computational tool describing all 
possible metabolic routes that could operate at steady-state (Schuster et al, 2000). Recent 
algorithmic improvements allow computing elementary flux modes for moderate size networks 
(Terzer & Stelling, 2008). However, the analysis of genome-scale metabolic networks still remains 
computationally challenging, due to the number of possible metabolic operation modes which grows 
exponentially with increasing network size and connectivity. In this thesis, metabolic networks are 
analyzed using constraint-based modeling approaches, and the current work does not involve 
network-based pathway analysis. Interested readers can find more information about network-based 
analytical tools in a recently published review (Trinh et al, 2009) 
  
* 
                                                          
*
 Figure source: http://imgs.xkcd.com/comics/forgot_algebra.png 
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Chapter 3  
Quantitative relationship between gene expression and metabolite 
levels is jointly determined by reaction mechanism and network 
connectivity 
Abstract* 
Metabolite levels and their turnover rates are the main determinants of cellular metabolic state, 
which can only be indirectly regulated by the cell. Transcription is the first step towards regulating 
metabolism and elucidation of its link to metabolite concentrations is a fundamental challenge in 
metabolic systems biology. At the level of individual reactions, intra-cellular metabolite levels are 
dependent on enzyme abundances through reaction kinetics mechanisms. Another mechanism of 
metabolite concentration control is due to network connectivity, which has remained relatively less 
elucidated. We hereby integrate these two distinct mechanisms and develop a modeling framework 
describing the interplay between metabolite concentrations, mRNA levels and fluxes. We illustrate 
the key role of network connectivity in determining quantitative relationship between gene 
expression and metabolite levels through the analysis of experimental data from Saccharomyces 
cerevisiae. The proposed methodology provides mechanistic explanation for the network-guided 
organization of transcriptional response in metabolic networks and represents a step towards 
unraveling the genotype-phenotype relationship. 
  
                                                          
*
 Manuscript in preparation: Zelezniak A, Sheridan S, Patil KR. Quantitative relationship between gene 
expression and metabolite levels is jointly determined by reaction mechanism and network connectivity 
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Introduction 
Regulation of intra-cellular metabolite levels in response to environmental and genetic changes is 
fundamental to the survival and evolution of organisms. Metabolism is one of the key cellular 
functionality at the interface of the genome and the organism’s environment. On the cell side, 
metabolism provides basic building blocks and energy for the growth and maintenance. On the 
environment side, metabolism exchanges material and energy with the surroundings to maintain 
thermodynamic feasibility of cellular processes. Genetically encoded messages thereby undertake a 
long journey, through complex multi-level interaction layers, down to functional enzymes, in order to 
regulate and drive life’s essential metabolic reactions. Emerging genome-wide bio-molecular 
abundance and interaction studies are providing snapshots of these regulatory networks (Costenoble 
et al, 2011; Fendt et al, 2010; Gallego et al, 2010; Li et al, 2010; Oliveira et al, 2008; Wang et al, 
2010). It has been clear that the adjustments in cellular metabolic phenotype (i.e., rates of reactions 
(fluxes) and metabolite levels) involve large numbers of changes at the gene expression levels 
(Murray et al, 2007; Tai et al, 2005; Tu et al, 2005). For example, previous studies have shown that 
the transcriptional regulation within metabolic networks is organized around perturbation-specific 
metabolites crucial for adjusting the network state (Patil & Nielsen, 2005; Zelezniak et al, 2010). 
Despite successful outcomes of these and other studies in linking gene expression with metabolites 
on a qualitative basis (Bradley et al, 2009; Keurentjes et al, 2006; Murray et al, 2007; Patil & Nielsen, 
2005; Urbanczyk-Wochniak et al, 2003), the quantitative relationship between the transcriptional 
response and the corresponding changes in metabolite levels has remained largely elusive. The task 
of predicting metabolite level changes based on gene expression is challenging due to multiple layers 
of regulation involved in-between (Figure 3.1A).  
We postulate that two primary mechanisms will largely determine the association between mRNA 
and metabolites, viz. reaction kinetics (which is non-linear by nature (Briggs & Haldane, 1925; 
Michaelis & Menten, 1913; Van Slyke & Cullen, 1914)) and mass flow constraints imposed by the 
network connectivity, i.e., balance between the production and the consumption of a metabolite. 
Role of reaction kinetics has been previously examined, albeit in the context of isolated reaction-
metabolite pairs. With such an approach, changes in metabolite levels could be explained to some 
extent when using protein abundance as a measure of enzyme availability; however, no correlation 
was observed in case of gene expression (Fendt et al, 2010). Detailed kinetic models and metabolic 
control analysis are useful tools to this end (Cleland, 1989; Klipp et al, 2005; Westerhoff & Chen, 
1984), but are currently limited by the lack of availability of in vivo kinetic parameters. Consequently, 
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detailed kinetic simulations are unsuitable for many biological studies where a comparison between 
two states/factors is the focus (e.g. healthy vs. disease state). 
 
Figure 3.1 From gene expression to metabolite levels. A) Metabolite levels are indirectly regulated at the genetic level, 
through enzyme abundance. Structural properties of an enzyme determine affinity for its substrate (KM), while the enzyme 
abundance limits the maximum substrate turnover rate (Vmax) achievable. Substrate concentration is linked with the 
reaction rate by non-linear MM kinetics, parameterized by KM and Vmax. Metabolites, in turn, can feedback to the enzyme 
regulation via potential interactions with proteins (Gallego et al, 2010) and/or mRNA (Hentze & Preiss, 2010). B) Transcript-
metabolite relationships are usually many-to-one. Either a single enzyme, or isoenzymes or a protein complex governs each 
reaction producing or consuming a metabolite. In our analysis, we discarded transcripts with insignificant changes (α = 0.05) 
across conditions (grey circles). For the remaining transcripts we combined the corresponding fold changes to derive gene-
expression scores for reactions and thereafter for consumption or production of metabolites. 
In vivo, most metabolites participate in multiple reactions and thus the abundance of enzymes 
catalyzing individual reactions will not completely determine metabolite’s fate, neither in terms of 
concentration nor fluxes. Indeed, correlations between mRNA and fluxes and even between enzyme 
activities and fluxes have often been found to be poor (Daran-Lapujade et al, 2007; Rossell et al, 
2005; Rossell et al, 2006; Yang et al, 2002a). On the other hand, studies utilizing network connectivity 
have been successful in establishing gene-expression-metabolite relationship, however, only of 
qualitative nature (Bradley et al, 2009; Hirai et al, 2005; Kresnowati et al, 2006; Murray et al, 2007; 
Urbanczyk-Wochniak et al, 2003). Here we propose an integrative model that couples both 
mechanisms of concentration control, i.e., reaction kinetics and network topology. In essence, the 
model embeds Michaelis-Menten kinetics into the metabolic network through the use of mass 
balance constraints. The model allowed us to link response at the level of metabolite concentration 
to the transcriptional fold changes in the neighboring as well as topologically distant genes. We 
verified the resulting model by analyzing publically available datasets reporting transcriptional and 
metabolic changes in the central carbon metabolism of the yeast Saccharomyces cerevisiae. 
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Results 
Starting from the classical Michaelis-Menten (MM) model – looking at each reaction as an isolated 
system consisting of a single enzyme and its substrate, we develop a network kinetics approach by 
accounting for the interactions between different reactions through shared metabolites. By analogy 
to flux coupling analysis, which describes how steady-state fluxes are linked to each other (Forster et 
al, 2003), we term our approach Concentration Change Coupling Analysis (CoCCoA). In view of the 
lack of genome-wide detailed information on in vivo enzyme mechanisms, we consider a single-
substrate MM kinetics for all reactions. According to MM kinetics, the flux or reaction rate V is a 
function of three parameters: i) concentration of substrate, S; ii) activity of enzyme, Vmax; and iii) 
enzyme properties, KM (Figure 3.1A). MM kinetics describes one enzyme – one substrate interaction. 
However, not only most intra-cellular metabolites participate in multiple reactions, several reactions 
are governed by multiple proteins (Forster et al, 2003). To account for these dependencies, reactions 
were classified in to three types: i) reactions controlled by a single enzyme, ii) reaction catalyzed by 
two or more isoenzymes, and iii) reactions catalyzed by enzyme complexes. For each reaction, we 
thereby chose the enzyme coding transcripts accordingly – in case of isoenzymes we average fold 
changes of transcripts, while for complexes we picked transcript with the lowest fold change. 
Applying these criteria, each reaction can be assigned a single fold-change value (in our analysis we 
used only significantly changed transcripts, α = 0.05) (Figure 3.1B). Finally, for each metabolite we 
calculate a gene-expression based concentration response score according to one of the CoCCoA 
equations, which are developed in the following. The overall workflow used for the analysis is 
depicted in Figure 3.2. Genome-scale metabolic reconstruction of S. cerevisiae (Forster et al, 2003) 
was used as a basis for obtaining the network connectivity as well as reaction directionality 
information. We used three different experimental datasets for evaluating the proposed CoCCoA 
models. For each dataset, we compared the experimentally observed metabolite concentration 
changes with the CoCCoA scores as calculated by using gene expression data. These case studies 
include one genetic and two environmental perturbations where both gene expression and 
metabolite concentrations had been measured in the same experiment (Methods). Significance of 
the observed correlations was evaluated against correlations obtained by randomly permuting 
metabolite and CoCCoA scores (Methods).  
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Figure 3.2 Schematic workflow of the algorithm used for the proposed concentration change coupling analysis. In the first 
step, physiological measurements from growth experiments are used to constrain the genome-scale metabolic model 
(Methods). Subsequent computational flux analysis (Methods) helps in identifying the directionality and range of fluxes 
under the two conditions being compared. Next, by using the comparative transcriptome data, fold changes at the 
individual gene-expression level are mapped on to the reactions in the network (Figure 3.1B). Concentration change 
coupling analysis integrates the mapped gene-expression data with the network topology by using a model formulation 
derived from reaction kinetics mechanism and mass balance constraints (main text). The main output from the algorithm is 
a measure of metabolite concentration changes between the two conditions, which are here tested for correlation with the 
experimentally measured metabolite abundance data.  
Depending on the extent to which the network connectivity information is included, the CoCCoA 
models are termed 0th, 1st or 2nd degree (Figure 3.3). 0th degree CoCCoA considers only the 
consumption of a metabolite and thus relying on enzyme kinetics. 1st degree CoCCoA accounts for 
the production of a metabolite in addition to its consumption by using mass balance constraints. 
Further expanding the scope of network connectivity accounted for in the model, the 2nd degree 
CoCCoA includes producing reactions of pre-cursors of the metabolite in question. The expansion of 
the network information on the production side of metabolite (and not consumption) is justified 
through mass balance and enzyme kinetic constraints as outlined in the following. 
Figure 3.3 Schematic representation of three CoCCoA models with varying degree of 
network constraints included. 0
th
 degree CoCCoA model includes information from 
reactions consuming substrate S and fluxes through these reactions. 1
st
 degree CoCCoA 
model expands to additionally include information from reactions producing 
metabolite S. In the 2
nd
 degree CoCCoA, additional data from production reactions of 
direct producers of S is included in the model formulation to explain changes in 
abundance of S. Concentrations of neighbors of metabolite S (grey circles) are not 
needed in CoCCoA models. 
 
0th degree concentration change coupling analysis  
We consider metabolite concentration changes relative to a reference condition – arbitrarily chosen 
from one of the two conditions pertaining to the experiment under investigation. Assuming that the 
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enzyme properties, represented by KM, remain unchanged in the experiment, by using MM kinetics 
one obtains (Supplementary notes): 
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Where * denotes the reference condition. The relative nature of this formulation allows 
circumventing the problem of the lack of availability of in vivo KM values. Furthermore, by assuming 
that maxVV  &
*
max
* VV  , and that the ratio  can be approximated by the gene 
expression ratio, equation (1) simplifies to a log-linear relationship (equation 2, Supplementary 
notes). Both of these assumptions are critically examined below. 
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The first assumption implies that the enzyme is not saturated – the opposite situation is not 
amenable for establishing the desired metabolite-gene expression (or enzyme availability in general) 
relationship, as the reaction velocity will then be only a weak function of metabolite concentration. 
Recent studies have shown that the in vivo concentration for several metabolites, esp. from central 
carbon metabolism, is close to the corresponding KM values (Bennett et al, 2009). At these 
concentrations (Gerosa & Sauer, 2011) reaction rates V are close to half of the Vmax. Although the 
assumption of V<<Vmax is not strictly applicable in this flux regime, numerical simulations show 
modest errors due to this approximation (around 20%, Supplementary Figure 3.1). Given the 
advantage that this approximation brings, namely elimination of need for knowing in vivo kinetic 
parameters, the cost of approximation error is rather low. This is an enabling assumption for linking 
transcriptome to metabolome, as currently no reliable estimates for in vivo kinetic parameters are 
available at the metabolic network scale. 
The second major assumption used in the current analysis is the proportionality between mRNA fold-
change and protein fold-change. Importantly, correlation between mRNA and protein abundances is 
not a necessity for our assumption, but only the correlation between the fold-changes of them across 
two conditions. This assumption is of particular relevance as the role of translation efficiency and 
post-translational modifications in regulating metabolic enzymes is becoming increasingly evident 
(Daran-Lapujade et al, 2007; Metallo & Vander Heiden, 2010; Oliveira & Sauer, 2012; Ptacek et al, 
2005). We here note that the CoCCoA framework is readily applicable to proteomics data. Currently 
max
*
max /VV
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there is lack of experimental data where both protein and metabolite abundances have been 
simultaneously measured in a network-wide manner. Nevertheless, we critically examined our 
hypothesis by analyzing published experimental data for S. cerevisiae where genome-wide mRNA and 
protein fold changes were simultaneously measured. Notably, correlations between mRNA and 
protein fold changes were found to be significantly stronger in the case of metabolic genes (Dataset 
from (Usaite et al, 2008a; Usaite et al, 2008b), R2 = 0.77, P = 0.04; R2 = 0.66, P = 0.0365, R2 = 0.76, P = 
0.0036; dataset from (Washburn et al, 2003), R2 = 0.4, P = 0.296; dataset from (Ideker et al, 2001), R2 
= 0.57, P = 0.0681; dataset from (Griffin et al, 2002), R2 = 0.43, P = 0.0001; P-values were estimated 
based on permutation test) (Figure 3.4A, Supplementary Figure 3.2). Interestingly, mRNA and 
protein changes have recently been demonstrated to be in good agreement even in mammalian 
systems (Schwanhausser et al, 2011).  
 
Figure 3.4 Correlation between protein abundance changes and the corresponding mRNA abundance changes is stronger 
for metabolic proteins. A) Black bars represent squared correlations including all proteins measured in each of the datasets. 
Grey bars are correlations only for metabolic proteins (as per genome –scale metabolic model by (Forster et al, 2003)). To 
assess the significance of obtained correlations, we calculated 10,000 different correlations between randomly chosen 
protein-transcript pairs (number of chosen pairs being equal to the number or metabolic protein measured in each 
dataset). P-value was estimated as a fraction of random correlations which were larger than those obtained for the 
metabolic proteins in the corresponding dataset. Each bar group represent different dataset (from left to right), 1,2,3 – 
(Usaite et al, 2008a; Usaite et al, 2008b), 4 – (Washburn et al, 2003), 5 – (Ideker et al, 2001), 6 – (Griffin et al, 2002). B) 
Distributions of P-values obtained for 1
st
 degree CoCCoA analysis accounting for the variability in mRNA-protein 
relationship. For each case study, P-values were obtained from 1,000 different correlations between metabolite 
concentration changes and 1
st
 degree CoCCoA score with correction factor for protein changes (see main text). Distributions 
are colored according to different datasets (Fendt et al, 2010; Kresnowati et al, 2006; Wisselink et al, 2010) used in the 
present work 
The model represented by equation 2 is hereby termed as 0th degree coupling, meaning that the 
metabolite S is not coupled to any other metabolite and connected only to the enzyme using it as a 
substrate (Figure 3.3). We note that under the condition of flux homeostasis, i.e. no flux change 
between the two conditions, metabolite concentration ratio becomes dependent only on the 
transcript changes. The flux homeostasis model of the 0th degree coupling is equivalent to the 
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protein-metabolite analysis proposed by Sauer and co-workers (Fendt et al, 2010). In contrast to the 
analysis in (Fendt et al, 2010), significant correlation (r = -0.68, P = 0.021, n = 11) resulted from 0th 
degree flux homeostasis analysis (Figure 3.5A), owing to the wider connectivity and hence the 
coverage of genes considered in the current analysis. In this case study, the observed physiology of 
the mutant showed 30% slower growth rate than the reference. Slower growth was concurrent with 
lower glucose uptake rate and implies large changes in intra-cellular fluxes spanning all major 
pathways. Indeed, we observed further improvement in the correlation by relaxing the assumption 
of flux homeostasis and thereby including the simulated flux data (Figure 3.5D) (Methods). For the 
other two datasets, however, the 0th degree coupling model failed to explain the observed metabolic 
changes (Figure 3.5B, C, E, F). Thus, in case of lack of reliable flux estimates on the network-wide 
scale (which are currently difficult to obtain; and flux simulations based on limited physiological data 
do not give unique solutions due to network complexity), the 0th degree model appears to be 
insufficient in terms of quantitatively connecting gene expression to metabolite levels. 
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Figure 3.5 Metabolite concentration changes are explained by transcriptional regulation score based on concentration 
changes coupling analysis. A) 0
th
 degree CoCCoA with the assumption of flux homeostasis, data from (Fendt et al, 2010); B) 
data from (Kresnowati et al, 2006); C) data from (Wisselink et al, 2010). D) 0
th
 degree CoCCoA, data from (Fendt et al, 2010); 
E) data from (Kresnowati et al, 2006); F) data from (Wisselink et al, 2010). G) 1
st
 degree CoCCoA, data from (Fendt et al, 
2010); H) data from (Kresnowati et al, 2006); I) data from (Wisselink et al, 2010). J) 2
nd
 degree CoCCoA, data from (Fendt et 
al, 2010); K) data from (Kresnowati et al, 2006); L) data from (Wisselink et al, 2010). Number of data points between 
coupling degree types can vary depending on number of connected genes (only significantly changed genes are considered, 
α = 0.05, two tailed) to metabolite at certain degree. Metabolite data represent experimentally measured values (log2-
scale) as reported in the original study. Notice, for the 0
th
 degree model (D, E, F) values on abscissa axis are different order 
of magnitude comparing to all others, since for these CoCCoA scores include simulated flux change estimations. Data points 
and regression lines are colored according to the degree of concentration changes coupling: orange – 0
th
 degree 
(homeostasis assumption), green – 0
th
 degree, red – 1
st
 degree, cyan – 2
nd
 degree. Grey points (I, L) represents metabolites 
(glucose 6-phopshate, glucose 1-phosphate, alpha,alpha'-trehalose 6-phosphate) with which were not possible to include in 
the analysis due to altered flux directions when grown on two different carbon sources. 
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1st degree concentration change coupling analysis 
In vivo, each metabolite pool is dependent on reaction consuming it as well as reactions producing it. 
At steady-state, sum of fluxes through the reactions that produce a particular metabolite, must be 
equal to the sum of the fluxes that use it as a substrate. For a metabolite with a single production 
reaction and a single consumption reaction, the steady-state assumption leads to equation (3) 
(Supplementary notes). 
****
lnlnlnln
R
R
T
T
T
T
S
S
cons
cons
prod
prod
    (3) 
Tprod and Tcons are gene expression levels corresponding to the enzymes producing and consuming S, 
respectively. R is concentration of pre-cursor metabolite of S. This relation implies metabolite 
concentration changes coupling between R and S and is defined as 1st degree coupling. Notably, the 
flux V is now eliminated and is accounted for by Tprod and R. Equation (3) brings a new network-
perspective to the enzyme kinetics and thus provides a mechanistic basis for including information 
from the network connections and corresponding bio-molecular abundances The link between 
metabolite and transcriptional changes now includes components from both consumption and 
production reactions of that metabolite (Figure 3.3). When multiple reactions are consuming (or 
producing) the same substrate S, the consumption (or production) term can be approximated by the 
average transcript ratios of the all consumption (or production) reactions (proof is provided in 
Supplementary notes). 
Using the above 1st degree concentration changes coupling model, we calculated correlation 
coefficients between metabolite concentration ratios and the 1st degree coupling score based on 
transcripts (first two terms on RHS of equation 3). Notably, we obtained significant correlations (P = 
0.003, n = 12; P = 0.02, n = 7; P = 0.023, n = 7) in all three case studies (Figure 3.5G, H, I), as opposed 
to the lack of, or weak, correlations in the case of 0th degree coupling. It is important to note that the 
number of metabolites that can be assigned CoCCoA score can vary between the coupling degrees. 
Since only significantly (α = 0.05, two tailed) changed transcripts are considered, the number of 
transcripts that can be used for calculation typically increase as more distant reaction nodes in the 
network are included. For example, in case of arabinose case study (Wisselink et al., 2010) (Figure 
3.5C, F), only three metabolites have significant transcript changes corresponding to their consuming 
reactions and hence only these can be compared against the experimental data. In contrast, 1st 
degree CoCCoA scores can be calculated for 7 metabolites. We also note that the proposed analysis 
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excludes reactions for which the flux directions switch between the conditions being compared. 
Consequently, the corresponding neighboring metabolites cannot be assigned CoCCoA scores. For 
example, metabolites shown as grey circles (Figure 3.5C, F). 
Network propagation of concentration control 
In a similar way as going from the 0th to the 1st degree coupling, one can further extend the degree of 
network propagation of concentration control by replacing the concentration ratio in the RHS of 
Equation 3 with the 1st degree CoCCoA relationship for the corresponding pre-cursor metabolites. In 
this fashion, we included the pre-cursor’s production reactions to derive the second-degree coupling 
relationship (Figure 3.3) (Supplementary notes). Interestingly, the 2nd degree correlations remained 
as strong as for the 1st degree for the first two case studies. This result is notable since the use of 2nd 
degree coupling involves expression data from the genes that are further away from the metabolites 
for which concentration is being predicted. Together, the results from the 1st and the 2nd degree 
coupling suggest that the majority of the control over concentration of a metabolite lies in its 
immediate neighbors in the network and the first-degree network connectivity appears to suffice in 
determining the fate of metabolite concentrations. 
An important observation from our analysis is that the slopes of the correlations (Figure 3.5) are 
consistent with the corresponding overall flux change inferred from the physiological data. In case of 
(Fendt et al, 2010) data (Figure 3.5A, D, G, J), fluxes in the mutant strain were lower compared to the 
wild type due to reduced growth rate. The same observation applies to the glucose pulse case study 
(Kresnowati et al, 2006) (Figure 3.5H, K). Flux through the glycolytic reactions was increased 
following the pulse and this is reflected in the observed positive slope (Figure 3.5B). According to the 
proposed models, we would expect to have positive slopes independent of the flux changes. The 
negative slope likely results from several unknowns, from network connectivity and/or from the 
reaction mechanism itself. These factors include, among others, reaction directions, allosteric 
regulation and relationship between gene/protein abundance and enzyme activity (for example, 
resulting from post-translational modifications). The lack of network-wide data for in vivo enzyme 
activities and reaction directions currently limit our explanation of this interesting observation to 
empirical and qualitative nature. Nevertheless, CoCCoA provides a modeling framework to 
systematically integrate such data in the future and thereby towards building a more predictive 
model. In the following, we illustrate how uncertainty in correlations between mRNA and protein can 
be included into CoCCoA.  
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Metabolic genes in yeast show significantly stronger correlation between mRNA and protein fold-
changes (Figure 3.4A, Supplementary Figure 3.2) in contrast to the other genes. Starting with the 
mRNA vs. protein fold change data for the yeast metabolic genes, we re-performed 1st degree 
CoCCoA whereas each transcript ratio was adjusted by using a randomly sampled correction factor. 
The space for this mRNA-protein fold change correction factor was estimated based on the slopes of 
linear regression lines between mRNA and protein fold changes across different datasets 
(Supplementary Figure 3.2, Supporting notes). We then examined whether the correlation between 
1st degree CoCCoA scores and metabolite fold changes remained significant in 1,000 simulations 
using mRNA-Protein correction factors. For all of the three case studies (Fendt et al, 2010; 
Kresnowati et al, 2006; Wisselink et al, 2010), large fraction of these simulations (99%, 86%, 91%) 
remained significant (Fisher transformation, α = 0.05) (Figure 3.4B), thereby indicating a high degree 
of robustness of CoCCoA towards different mRNA/Protein fold change ratios for different genes. 
All three case studies examined above covered metabolites participating in the central carbon 
metabolism. In case of the certain enzymes from these and other pathways, for example amino acid 
metabolism, regulation by other mechanisms such as allosteric inhibition (Braus, 1991) may play a 
dominant role (Luttik et al; Metallo & Vander Heiden, 2010). Furthermore, in the case of enzymes 
saturated with their substrates, reaction rates (according to MM kinetics) will be decoupled from 
metabolite concentrations. When larger scale quantitative metabolomics data becomes available in 
the future, mechanisms in addition to those considered here, for example substrate inhibition, multi-
substrate reaction mechanisms (Cleland, 1989) or allosteric regulation may need to be invoked in 
order to link metabolite concentrations with the enzyme abundance and hence to gene expression. 
Discussion 
One of the main observations from our results (Figure 3.5) is that the correlation between 
metabolites and transcripts becomes evident only when including network flow constraints. This 
suggests that the network connectivity component is important element that brings missing part to 
gene expression-metabolite puzzle. The use of genome-scale metabolic model allowed us to exploit 
the network connectivity element to a very high degree. For example, even for a sparsely connected 
metabolite such as D-Ribose 5-phosphate, the 2nd degree CoCCoA score accounts for transcriptional 
information from 17 genes (with significant change in gene expression), whereas 0th degree score 
accounts for only 2 transcripts (Figure 3.6A). Highly connected metabolic cofactors such as ATP and 
NADH also contributed to the observed correlations based on our results (Figure 3.5A, D, G, J, 
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Supplementary Figure 3.3). Given the importance of these hub metabolites in several human health 
and biotechnological problems (Brochado et al, 2010; Hahn-Hagerdal et al, 1996; Zelezniak et al, 
2010)), CoCCoA represents a step towards understanding the transcriptional control of these pools. 
These results suggest a dominant contribution of the network flow constraints to the metabolite 
concentration control – in addition to the substrate-enzyme relationship given by the reaction 
mechanism. Expanding the network information beyond the first-degree neighbors appears to have a 
perturbation specific impact on the corresponding metabolite-gene expression relationship. As the 
degree of network connectivity in CoCCoA increases, larger numbers of new genes become part of 
the CoCCoA score for any given metabolite (Figure 3.6B). Importantly, inclusion of many new genes 
when moving from 1st to 2nd degree CoCCoA in general maintains the correlation (Figure 3.5). This 
observation suggests a strong co-regulation of genes that are linked through common 
substrates/products. Indeed, co-expression of metabolic genes on short network distances has been 
observed earlier (Kharchenko et al, 2005). CoCCoA thus provides a mechanistic explanation for the 
role of network topology in regulating global metabolite concentration changes. In particular, 
inclusion of production reactions (1st degree CoCCoA) due to mass balance constraints makes a major 
contribution in explaining metabolite pool changes. 
To what extent the discrepancy between mRNA and protein levels may explain the remaining 
variance in the metabolite-mRNA correlations predicted by CoCCoA? Single-experiment 
transcriptomics-proteomics datasets (Griffin et al, 2002; Ideker et al, 2001; Usaite et al, 2008a; Usaite 
et al, 2008b; Washburn et al, 2003) allowed us to examine the mRNA-protein correlations from the 
metabolism point of view. An interesting finding is that metabolic genes in yeast display significantly 
stronger correlation between mRNA and protein fold-changes as opposed to the genes involved in 
other cellular processes (Figure 3.4A, Supplementary Figure 3.2). It remains to be seen whether the 
enriched correlation between transcript and protein levels in metabolism extends to the enzyme 
activity. Increasing availability of genome-wide protein phosphorylation/acetylation data may aid in 
addressing this question. Any such information at protein abundance/activity level can be integrated 
in to the CoCCoA formulation in a straightforward manner – by substituting the corresponding 
transcript ratio terms by the protein abundance or activity measures. In light of the currently known 
variability of mRNA-protein ratios, CoCCoA remains valid when gene expression changes are 
corrected for the expected response at the level of proteins (Figure 3.4B). 
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Figure 3.6 Gene coverage in CoCCoA case studies. A) Number of significantly changed genes increase with CoCCoA degree. 
B) Overlaps of significantly changed genes used for calculation of CoCCoA scores for all metabolites from different case 
studies. Number of genes that overlap across different case studies is relatively low, confirming the fundamentally different 
nature of the underlying perturbations. Case studies used in the present work: (Fendt et al, 2010; Kresnowati et al, 2006; 
Wisselink et al, 2010). 
Formulation of CoCCoA in a relative manner, i.e. in the fold-change space, allows circumventing the 
problem of unknown in vivo kinetic parameters. A major advantage following this is that the CoCCoA 
models neither need any parameter fitting procedure nor need to be adjusted to any particular 
experiment. In contrast, kinetic models rely on parameter estimation from observed data, which 
makes model extrapolation across experiments difficult and dramatically increases the number of 
assumptions. Concentration change coupling analysis represents a step towards integrating kinetic 
and steady-state modeling approaches at the network-scale. 
CoCCoA models do not require time-course experiments and can be applied to studies designed as 
comparison between two factors, e.g. wild-type vs. mutant cells. Indeed, the applicability of CoCCoA 
was found to be quite general in terms of the experimental design underlying the data. Our results 
demonstrate the applicability for three fundamentally different and biologically relevant 
perturbations – mutant/wild-type, environmental perturbation and adaptive evolution. These three 
case studies also comprise of two biologically different growth conditions, batch (Fendt et al, 2010) 
and chemostat (Kresnowati et al, 2006; Wisselink et al, 2010). The difference in the nature of these 
perturbations is reflected in the fact that despite the concentration changes within the same 
metabolic pathways are detected in these studies; gene expression changes have only small overlap 
(Figure 3.6B). This attests the generality of the CoCCoA model as well as empirically shows its 
robustness for application to different biological perturbations.  
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CoCCoA models explain more than 60% of the variation in metabolite changes based on changes in 
expression of the genes coding for producer and consumer enzymes of these metabolites. This result 
strongly suggests that the proposed (log-) linear relationships between metabolite and gene 
expression changes are biologically meaningful. Quantitative predictions for the slopes of the 
corresponding regression lines will be a major challenge for the future modeling work. In the current 
work, we observe that the sign of the CoCCoA-metabolite relationship matches with the up/down 
regulation of fluxes from that of the reference state. 
Application of CoCCoA is not possible in the case of perturbations that are likely to drastically affect 
properties of several enzymes. Furthermore, metabolite-enzyme pairs where metabolite 
concentrations are likely to be above their KM values (Bennett et al, 2009; Gerosa & Sauer, 2011) the 
relationship between metabolite and enzymes will be largely independent of changes in enzyme 
abundances. In higher eukaryotes such as plants or mammalian cells (Urbanczyk-Wochniak et al, 
2003), potential influence of compartmentalization, feedback regulation, among others, will have 
important effects and new methods need to be developed to address these. For example, genome-
wide metabolite profiling in plants and their associations with genomic and phenotypic traits can 
provide a valuable starting points towards this (Schauer et al, 2006). 
In conclusion, concentration change coupling analysis yielded so far best-known correlations 
between gene expression and metabolite levels. CoCCoA provides a framework towards bridging the 
gap between functional genotype and the observed metabolic phenotype. In the yeast central 
carbon metabolism, this bridge appears to be supported on the transcriptional regulation operating 
around the metabolites. 
Methods 
Datasets 
The first dataset (Fendt et al, 2010) consists of a comparison of a reference yeast strain with GCR2 
null mutant. GCR2 is a transcription factor responsible for activation of glycolytic genes (Uemura & 
Jigami, 1992). In the second case study (Kresnowati et al, 2006), S. cerevisiae was grown in carbon-
limited chemostat cultures and was subjected to a pulse change in glucose concentration. In the third 
dataset (Wisselink et al, 2010), an evolutionarily engineered yeast strain was grown on glucose or 
arabinose as a sole carbon source. Summary of growth conditions and descriptions of datasets from 
all case studies is provided in Supplementary Table 3.3. Metabolite data was used as reported in the 
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original studies; significance cut-off α = 10% was chosen to control for type 1 error of null hypothesis 
that mean metabolite concentrations between two conditions are equal. 
Metabolic network and flux variability analysis 
Genome-scale reconstruction of Saccharomyces cerevisiae metabolic network by (Forster et al, 2003) 
was used to link metabolites with the enzyme-coding genes. A total of 708 structural open reading 
frames (ORFs) are accounted for in this network, representing 1035 metabolic reactions (in total 
1175 reactions and 584 metabolites). For each of the case studies, reaction directions were 
estimated by using flux variability analysis (Mahadevan & Schilling, 2003). The steady-state model 
was constrained with the corresponding physiological data as reported for the corresponding case 
studies (Supplementary Table 3.1, Supplementary Table 3.2, Supplementary Table 3.3, 
Supplementary Table 3.4, Supplementary Table 3.5). Resulting linear programming problems were 
solved using glpk (http://www.gnu.org/software/glpk/) solver accessed through a C library. Flux fold-
change data required for the 0th degree concentration changes coupling scores were estimated as 
ratios of average of the minimum and maximum feasible flux before and after perturbation. 
Transcription data analysis 
Preprocessing of the Affymetrix CELL files was carried out by using the statistical software 
environment R/Bioconductor (http://www.bioconductor.org). Resulting probe intensities were 
corrected for background by using robust multi-array average method (Irizarry et al, 2003 2003) 
(RMA) using only perfect-match (PM) probes. Normalization was performed by using the quantiles 
algorithm. Gene expression intensity values were calculated from the PM probes using median polish 
summarization method (Irizarry et al, 2003 2003). Significance of the differential expression was 
calculated by using the empirical Bayes test implemented in limma package (Smyth, 2004).  
Statistical analysis 
Pearson correlation coefficients between log2 metabolite fold changes and concentration changes 
coupling scores were calculated with statistical software R (http://www.r-project.org) by using linear 
model fitting function lm. Metabolite changes were used as dependent variables and CoCCoA scores 
as independent. P-values for null hypothesis of no correlation (regression slope = 0) were estimated 
by applying anova function to linear model (lm) object. In addition, we performed a permutation test 
for correlations between metabolite fold changes (log2) and CoCCoA scores. The originally paired 
data was randomly permuted without replacement for 10,000 times. For each permutation, a 
correlation coefficient was calculated and the P-value was estimated as a fraction of squared 
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correlation coefficients which were larger than in the original paired data. The results were similar to 
those estimated by anova function. 
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Supplementary notes 
0th degree concentration change coupling 
 
Michaelis-Menten kinetics equation is given by: 
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Rearranging for S: 
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Dividing Eq.1 by reference condition gives: 
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Assuming that V<<Vmax & V*<<Vmax* (see main text for assumption discussion) one gets: 
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*
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V
V
V
S
S
  (3) 
Transforming to log-space Eq. 3 becomes: 
max
*
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lnlnln
V
V
V
V
S
S
   
Since Vmax = k2[E], where k2 and [E] are substrate to product conversion rate and concentration of 
enzyme of active enzyme, respectively. Assuming that E ∝ T, there T is transcript abundance, and 
that k2 is not changing between two conditions, one gets: 
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Eq. 4 is defined as 0th degree concentration change coupling. 
1st degree concentration change coupling§  
 
At steady-state Vin =Vout, consequently: 
**
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Substituting flux ratio in above equation by metabolite and transcript ratios as given by Eq.4, we 
obtain: 
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Since the consuming reaction of R is the same as the production reaction of S, prod
R
cons TT  . 
Rearranging for S thereby gives: 
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Eq. 5 is defined as 1st degree concentration change coupling. 
§
In presented scheme, Umax is equivalent of      
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2nd degree concentration change coupling§ 
 
Applying first degree CoCCoA (Eq.5) to metabolite R, gives: 
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Eq. 7 is defined as 2nd degree concentration change coupling.  
§
In presented scheme, Umax is equivalent of      
    and Wmax is related to the production of metabolite R 
Multiple reactions connected to S 
0th degree concentration change coupling 
 
Two reaction using the same substrate S. Only for consumption reactions 0
th
 degree concentration change coupling. U and 
V represent fluxes through the two reactions. 
Let’s consider two reaction carrying flux U and V use the same substrate S. For each reaction, 0th 
degree concentration change coupling (Eq.4) can be applied independently 
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Above system of two equations can be summed and rearranged as: 
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For more than two reactions, similar analysis will imply averaging of fold changes of the 
corresponding transcripts; see also Figure 3.1B in the main text. 
1st degree concentration change coupling 
 
Multiple reactions producing same metabolite, 1
st
 degree concentration change coupling 
At steady-state: 
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Comparing to the reference: 
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Let’s define f1=αf2  (or f2=βf1 ) correspondingly for reference condition, then: 
*
3
3
**
1
1 ln
)1(
)1(
ln
f
f
f
f










 
It was shown that flux ratio, for the most of perturbations, do not change (Haverkorn van Rijsewijk et 
al, 2011), thus we can consider α=α* and β=β*, i.e. the split ratio of fluxes between conditions is not 
changing, then: 
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Rearrangement of Eq.9 using Eq.4 gives: 
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Equation 10 was used as a basis for calculation of 1st degree concentration change couplings; see also 
Figure 3.4B in the main text. 
1st degree concentration change coupling with protein-mRNA correlation correction factor 
****
lnlnlnln
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S
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prodcons
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cons    
Each transcript change term 
*
ln
T
T
 was multiplied by correction factor β, which was estimated as a 
regression slope coefficient randomly sampled from normal distribution with mean and variance 
determined from least squares regression lines slopes of metabolic mRNA-protein fold changes 
correlations (Supplementary Figure 3.2). Data from studies (Griffin et al, 2002; Usaite et al, 2008a; 
Usaite et al, 2008b) with P-value < 0.05 (Supplementary Figure 3.2) was used for making distribution 
of slopes.  
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Supplementary Figure 3.1 Metabolite concentration change error as a function V/Vmax(respectively V
*
/Vmax
*
). In a standard 
Michaelis-Menten kinetics mechanism, KM is a concentration there enzyme is half-saturated and reaction rate V = 0.5 Vmax 
When substrate concentration reaches its KM value (at reaction rates 0.25Vmax-0.5Vmax), in order to explain metabolite 
concentration changes one needs to consider V (respectively V
*
). In low flux ranges 0.1Vmax-0.25Vmax (respectively 0.1Vmax
*
-
0.25Vmax
*
) which is of order magnitude of KM, metabolite concentration change can be explained under assumption 
(V<<Vmax) with reasonable error. Error is defined by equation 11. 
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Supplementary Figure 3.2 Correlation between protein abundance changes and the corresponding mRNA abundance 
changes is stronger for metabolic proteins. A, D, G, J, M, P) Correlation including all proteins measured in each of the 
datasets. B, E, H, K, N, Q) Correlation only for the metabolic proteins (as per genome-scale metabolic model by (Forster et 
al, 2003)) measured in each of the datasets. C, F, I, L, O, R) Histogram of correlation coefficients obtained for 10,000 
different correlations between randomly chosen protein-transcript pairs (number of chosen pairs being equal to the 
number of metabolic proteins measured in each dataset). Blue area denotes number of times when random correlations 
were higher than those obtained for the metabolic proteins in the corresponding dataset. Each row of plots represents a 
different dataset (from top to bottom), 1, 2, 3 –(Usaite et al, 2008a; Usaite et al, 2008b) ; 4 –(Washburn et al, 2003); 5 – 
(Ideker et al, 2001); 6 –(Griffin et al, 2002)  
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Supplementary Figure 3.3 Concentration change coupling for hub metabolites. Correlations between metabolite changes 
and concentration change coupling (CoCCoA) scores (derived from gene expression data). Data from (Fendt et al, 2010). The 
plots are the same as in Figure 3.5 (main text), except that the highly connected metabolites are marked. a) 0
th
 degree 
CoCCoA with the assumption of flux homeostasis; b) 0
th
 degree CoCCoA; c) 1
st
 degree CoCCoA; d) 2
nd
 degree CoCCoA. Data 
points and regression lines are colored according to the degree of concentration change coupling: orange 0
th
 degree 
(homeostasis assumption), green 0
th
 degree, red 1
st
 degree, cyan 2
nd
 degree.  
  
4
4
 Supplementary Table 3.1 Summary of growth condition from all case studies used in analysis. Results from case studies 1, 2 and 3 are described in main text. 
Study # Reference Growth conditions Short description Comparison Remarks 
1 (Fendt et al, 2010) 
Batch (shake flask), 
aerobic, glucose 
minimal medium 
Compares Gcr2p null 
mutant with reference 
yeast strain. Gcr2p 
responsible for 
activation of glycolysis. 
Measurements are 
taken at exponential 
growth phase. 
∆gcr2 mutant vs. wild-
type yeast 
Growth rate of mutant was 30% 
slower than wild-type FY4.  
2 (Kresnowati et al, 2006) 
Chemostat, aerobic, 
glucose limited 
Growing glucose-limited 
chemostat culture is 
subjected to glucose 
pulse. Data is collected 
at different time points 
before and after pulse. 
300s after glucose pulse 
vs. time before pulse 0s 
Time point of 300s was chosen to 
account for time needed for 
transcription to affect metabolite 
levels. 
3 (Wisselink et al, 2010) 
Chemostat, 
anaerobic, arabinose 
and glucose limited 
Evolutionary adapted 
strain which is able to 
grow on arabinose was 
grown on arabinose or 
glucose. 
Growth on arabinose of  
adapted vs. growth on 
glucose of adapted strain 
For 0
th
 degree concentration change 
coupling only 3 points could be 
potentially used for correlation 
analysis (no significantly changed 
transcripts in consumption reactions)  
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Supplementary Table 3.2 Physiological data from case study 1 (Fendt et al, 2010). Comma-separated values denote lower 
and upper bounds used for constraining the corresponding fluxes.  
Reaction (mmol/g/h) ∆gcr2 WT 
Glucose uptake 10, 11 16.15, 17.85 
Ethanol secretion rate 14, 15 20, 22 
Glycerol secretion rate 1.66, 2.07 2, 2.2 
Acetate secretion rate 0.5,0.7 0.75, 1.51 
Pyruvate secretion rate 0.04, 0.06 0.06, 0.09 
Growth rate 0.2,0.26 0.3, 0.33 
 
Supplementary Table 3.3 Physiological data from case study 2 (Kresnowati et al, 2006). Parameters were estimated for 
300s time point by using the plots provided in the original publication. Comma-separated values denote lower and upper 
bounds used for constraining the corresponding fluxes constraints. 
Reaction (mmol/g/h) 300s 0s 
Glucose uptake 3.6, 3.8 0.45, 0.6 
Oxygen uptake 4.2, 4.4 1.55, 1.8 
Ethanol secretion rate 2.75, 2.9 - 
Acetate secretion rate 0.5, 0.6 - 
Glycerol secretion rate 0.14, 0.16 - 
Growth rate 1.66, 2.07 0.04, 0.048 
 
Supplementary Table 3.4 Physiological data from case study 3 (Wisselink et al, 2010). Comma-separated values denote 
lower and upper bounds used for constraining the corresponding fluxes constraints. 
Reaction (mmol[CmolDW]
-1
 h
-1
) Arabinose Glucose 
“Arabinose”*/Glucose uptake 61, 62 59, 63 
Ethanol secretion rate 91.1, 104.5 96, 108 
CO2 secretion rate 97, 110 100, 112.8 
Succinate secretion rate 0.29, 0.37 0.2, 0.5 
Glycerol secretion rate 6.85, 7.15 6.9, 7.9 
Acetate secretion rate 0.45, 0.81 0.376, 0.42 
Pyruvate secretion rate 0.046, 0.054 0.066, 0.074 
Growth rate 1.6, 1.66 1.45, 1.55 
*Growth on glucose was used to estimate reaction directions. Note: CoCCoA cannot be used if many reaction directions are 
changing between the two conditions tested. In this case, however, according to (Wisselink et al, 2010), the difference in 
reaction directions are confined only for few fluxes. This enabled us to perform CoCCoA.  
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Supplementary Table 3.5 Changes in reaction directions used in case study 1 and 2. Glycolytic flux directions were fixed 
according to (Fendt et al, 2010). For other reactions, directions based on other literature indications were used. 
Reaction name in the model Reaction Remarks 
Glycolysis   
PGI1_1 alpha-D-Glucose 6-phosphate -> beta-D-Fructose 6-phosphate  
PGI1_2  alpha-D-Glucose 6-phosphate -> beta-D-Glucose 6-phosphate  
PGI1_3 beta-D-Glucose 6-phosphate -> beta-D-Fructose 6-phosphate  
FBA1 beta-D-Fructose 1,6-bisphosphate -> D-Glyceraldehyde 3-phosphate + Glycerone 
phosphate 
 
TDH1|TDH2|TDH3 D-Glyceraldehyde 3-phosphate + NAD+ + Orthophosphate -> 3-Phospho-D-
glyceroyl phosphate + NADH 
 
PGK1 3-Phospho-D-glyceroyl phosphate + ADP -> 3-Phospho-D-glycerate + ATP  
GPM1_1 3-Phospho-D-glyceroyl phosphate -> 2,3-Bisphospho-D-glycerate  
GPM1_2|GPM2|GPM3 3-Phospho-D-glycerate -> 2-Phospho-D-glycerate  
ENO1|ENO2|ERR1_1|ERR1_2|ERR2 2-Phospho-D-glycerate -> Phosphoenolpyruvate  
ACO1|YJL200C CitrateM -> IsocitrateM  
LSC1  ATPM + CoAM + ItaconateM -> ADPM + Itaconyl-CoAM + OrthophosphateM   
LSC2 ATPM + CoAM + SuccinateM -> ADPM + OrthophosphateM + Succinyl-CoAM  
FUM1_1 FumarateM -> MalateM  
FUM1_2 Fumarate -> Malate  
Amino acid metabolism   
SHM1 L-SerineM + TetrahydrofolateM -> 5,10-MethylenetetrahydrofolateM + GlycineM  
SHM2 L-Serine + Tetrahydrofolate -> 5,10-Methylenetetrahydrofolate + Glycine  
GDH2 L-Glutamate + NAD+ -> 2-Oxoglutarate + NADH + NH3 Reaction 
removed 
OAC1  Oxaloacetate -> H+M + OxaloacetateM  
DIC1_1 Malate + SuccinateM -> MalateM + Succinate  
YDR111C L-Glutamate + Pyruvate -> 2-Oxoglutarate + L-Alanine  
YFL030W Glycine + Pyruvate -> Glyoxylate + L-Alanine  
CTP1_1 Citrate + MalateM -> CitrateM + Malate  
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Chapter 4  
Network architecture imparts plasticity to transcriptional regulation 
in the yeast metabolic network 
Introduction 
Studies of structural organization of metabolic network have provided a first at glance of properties 
and organization of metabolic networks (Albert, 2005; Csete & Doyle, 2004). Although information 
about topological characteristics is very useful, it provides only a static description of biological 
networks (Kharchenko et al, 2005). In reality, metabolic networks are subject to tight regulation at a 
number of levels including, transcriptional regulation. Previous studies have shown that functionally 
connected genes are often co-regulated (Gavin et al, 2002; Hartwell et al; Lee et al, 2002). Earlier 
observations suggested that co-regulated genes are often arranged in a linear order (Ihmels et al, 
2004). Moreover, it was demonstrated that in metabolic networks, closely connected genes display 
significant co-regulation (Kharchenko et al, 2005). In our previous study (Chapter 3) we show that 
changes of metabolite concentrations to some extend are explained by difference of average 
changes in expression of genes neighboring it. By applying same principles (see Chapter 3), here, we 
demonstrate several novel aspects of transcriptional regulation in metabolic network of 
Saccharomyces cerevisiae.  
Using gene expression data from multiple environmental/genetic perturbation experiments 
(Materials and Methods) we show that expression of genes centered around a metabolite can be 
regulated in three different ways. While some metabolites show a strong co-expression in only a few 
of its producing enzymes and consuming enzymes, their collective action tends to be coordinated. 
We suggest a new emergent type of regulation which accounts for all incoming and outgoing genes 
for a given metabolite. We show that emergent co-regulation is dominant among many metabolites 
in the metabolic network of S. cerevisiae. 
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Results and discussion 
Previous studies have investigated the co-regulation of reaction around a metabolite by computing 
the correlation coefficients of the changes in gene expressions for corresponding enzymes across 
many experiments (Ihmels et al, 2004; Kharchenko et al, 2005). Earlier data suggested that metabolic 
genes in individual pathways were co-expressed, and as such, at divergent pathway branch points 
(for a given metabolite incoming reaction and two outgoing reactions), the expression of the 
incoming reaction was seen in the majority of cases to be correlated with only one of the two 
outgoing reactions (Ihmels et al, 2004). The past studies did not consider more than two incoming-
outgoing reaction pairs at once. However, in our previous work (Chapter 3), we showed that changes 
of metabolite concentration are correlated with collective changes of genes neighboring it. 
Therefore, we hypothesize that metabolite concentration are dependent on overall action of 
enzymes neighboring it and expression of these enzymes are coordinated. In other words, to 
maintain homeostasis of the system and control metabolite concentration levels, changes of the 
metabolite’s producing (input) genes must be co-regulated with consuming (output) genes. 
To systematically examine the transcriptional regulation of the metabolic network of S. cerevisiae, 
we assembled a large gene expression dataset (Materials and Methods) spanning a variety of 
environmental and genetic perturbations experiments. In the metabolic network of S. cerevisiae 
(Forster et al, 2003) 34% of reactions are reversible; to ensure which metabolites are being 
produced/consumed, we therefore applied a criteria that the carbon source used in selected 
experiments had to be of glycolytic nature (Materials and Methods).  
For all metabolic genes a fold change value can be calculated for each comparison between groups of 
samples in each experiment (Materials and Methods). By comparing the fold changes of each 
comparison for all input-output genes, a correlation coefficient can be calculated to measure the 
degree of co-regulation for the pair of genes. Alternately, the fold changes of all incoming reactions 
can be averaged for each comparison, and compared against the average fold change of all outgoing 
reactions for each comparison, to determine a single correlation coefficient for each metabolite, 
representing the collective co-regulation of all incoming and all outgoing reactions (Figure 4.1A). By 
computing correlation coefficients for all gene pairs, we found that coefficients of all in-out pairs are 
slightly higher than a control of random gene pairs (P-value < 10-7, Wilcoxon rank sum test) (Figure 
4.1B). In contrast, the correlation coefficients of the averages of production reactions vs. 
consumption reactions overall are noticeably higher than a control in which gene identities are 
shuffled (P-value < 10-7, Wilcoxon rank sum test) (Figure 4.1C). 
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Figure 4.1 Correlation between metabolite neighbor genes. A) Metabolite can be a product of reactions (input reactions of 
metabolite S) and can participate in reactions as a substrate (output reactions of metabolite S). By comparing the fold 
changes in each comparison for all input-output genes pairs (those which code for the corresponding enzymes), a 
correlation coefficient is calculated to measure the degree of co-regulation for the pair of genes. Similarly, average of fold 
changes of inputs genes is correlated against average of all output genes across all comparison. To avoid autocorrelation 
transcripts coding enzymes performing sequential reactions were removed from analysis. After performing flux variability 
analysis, remained reversible reactions were removed from calculations (Materials and Methods). B) Distribution of the 
correlation coefficients between input vs. output gene pairs. For comparison, a random control was constructed by 
shuffling the identities of each gene 1000 times while preserving the connectivity of each metabolite. Importantly, only 
genes coding for enzymes were used in the random control. C) Distribution of correlation coefficients of average input 
genes vs. average output. Random control was computed as in B panel. 
Subsequently, for each metabolite we compared correlation patterns of all producing-consuming 
gene pairs with correlations of averages expression changes of production-consumption genes 
(Supplementary Figure 4.1). A number of metabolites (e.g. NADPH, alpha-D-Glucose, Acetaldehyde) 
showed a high correlation for certain in-out pairs. In contrast, co-expression of consuming and 
producing genes was very low for these metabolites, suggesting a linear pathway-oriented regulation 
(Supplementary Figure 4.1). Another group of metabolites (e.g. Glycogen, Ubiqunol mitochnodrial, 
S−Adenosyl−L−homocysteine) showed a uniform regulation irrespective of its pathway, which was 
displayed by generally high correlation for in-out pairs, with a corresponding high co-regulation seen 
in producing-consuming averages. Strikingly, correlations of averages of producing vs. consuming 
genes were higher than in any individual producing-consuming gene-pairs for a considerable amount 
of metabolites (~15 %) showing an emergent type of regulation. Figure 4.2 illustrates three potential 
regulatory schemes. 
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Figure 4.2 Three potential regulatory schemes and their signature co-regulation patterns. Linear pathway-oriented 
regulation would have a sparse highly-correlated in-out pairs, and low average-in-average-out correlation. Uniform 
metabolite-oriented regulation would show generally high correlations for in-out pairs, with a correspondingly high 
average-in-average-out correlation. Emergent regulation would have a variety of low-to-moderate correlations of in-out 
pairs, with an average-in-average-out correlation above the average correlation of pairs or above the maximum correlation 
of pairs. NADPH – Nicotinamide adenine dinucleotide phosphate; GLC – alpha-D-Glucose; AcALD – acetaldehyde; GCN – 
glycogen; UBQ(M) – Ubiquitinol mitochondrial; SAH – S−Adenosyl-L-homocysteine; ICI – isocitrate; CoA – Coenzyme A; R5P 
– ribose 5-phosphate.  
The proposed uniform regulation of incoming reactions and outgoing reactions fits with our finding 
of strong correlations between average incoming fold changes with average outgoing fold changes 
(Figure 4.1C). This perspective of metabolite-oriented regulation does not contradict the perspective 
of pathway-oriented regulation; it expands upon it, by recognizing that many metabolites belongs to 
more than one pathway that tends to be co-regulated. If different needs in the metabolic network 
are met by co-regulation of different in-out pairs around a metabolite, but steady-state is maintained 
(i.e. the net change in production is always matched by changes in consumption, and vice versa), 
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then a metabolite’s quantity is not strictly set by regulation of single pathway; instead, it emerges 
from variable network regulation. That is, the average of incoming fold changes will always be 
correlated with the average of outgoing fold changes, even if no single in-out pair is correlated all the 
time and some pairs are never correlated.  
Such emergent regulation of the metabolite’s quantity, distributed between various pathways, would 
be characterized by a correlation coefficient ρ between average producing reaction and average 
consuming reactions greater than the average ρ of all in-out pairs for that metabolite. Indeed, the ρ 
of averages was greater than the average genes expression correlation of in-out pairs for most 
metabolites (Figure 4.3B). In fact, in an idealized case, in which most pairs are correlated for a subset 
of the points, the ρ of average producing vs. the average consuming reactions would exceed the 
correlation coefficient of any in-out pair. Indeed, we found this to be true of 18 metabolites of the 
145 that retained at least two in-out pairs after removal of reactions that are reversible and which 
input output was controlled by the same enzymes, and many more had correlations of the averages 
approaching that of the maximum in-out pair Figure 4.3A. 
 
Figure 4.3 An emergent regulatory effect is found in a majority of metabolites. A) A collective action of all producing-
consuming genes is higher than maximum individual pair (gain) for 13% of metabolites (red bubbles). The size of bubble is 
proportional to 2*log10(number of in-out gene pairs). Metabolites having at least two in-out pairs are displayed accounting 
for a minimum of 3 genes. B) For majority of metabolites, correlation coefficients of average in-out are higher than average 
correlation of in-out pairs (above diagonal line). Red bubbles are the same as marked in panel A. 
Our findings can be rationalized by the recognition that metabolites and their fluxes are the objects 
of metabolic regulation, and enzymes are merely the tools by which the cell manipulates 
concentration levels and fluxes. In most cases, a cell will have an interest in ensuring that 
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intermediate metabolite concentrations neither rise nor fall dramatically. In order to maintain such a 
balance, a metabolite’s total incoming flux must match its total outgoing flux, but the particular route 
is unimportant from the perspective of maintaining the metabolite’s concentration. The average 
gene expression fold change of the incoming reactions is correlated with the average fold change of 
the outgoing reactions in majority of metabolites. Such an emergent collective regulation of a 
metabolite’s reactions is observed as a general co-expression pattern in metabolic network of 
Saccharomyces cerevisiae (Figure 4.4). 
 
Figure 4.4 Emergent metabolite regulation in yeast metabolic network. Highlighted metabolites shows emergent co-
regulation pattern. Figure was generated using: http://pathways.embl.de/ 
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Materials and Methods 
Datasets 
ArrayExpress database was searched for term “glucose” and organism “Saccharomyces cerevisiae”, 
choosing only Affymetrix platform microarrays. Of the 69 datasets returned, we hand-selected only 
those which had a glycolytic carbon source, leaving 22. Each dataset consists of the data from a 
number of different microarray chips. Datasets were parsed to detect experimental factors, and then 
grouped the data from each chip based on these factors. All combinations of factors were tried, from 
grouping samples (chips) by all factors to grouping them by only one at a time. If multiple factors 
were used to group samples, only groups that differed in one factor were compared against each 
other, making in total 118 comparisons. Probes were annotated with the ‘annotate’ package from 
Bioconductor (Gentleman et al, 2004); For each comparison between groups, each probe’s signal was 
averaged among all the chips in the group, and fold change between the two groups’ averages for 
each probe was calculated.  
Metabolic network and flux variability analysis 
Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network by (Forster et al, 
2003) was used to link metabolites with the enzyme-coding genes. A total of 708 structural open 
reading frames (ORFs) are accounted for in this network, representing 1035 metabolic reactions (in 
total 1175 reactions and 584 metabolites). Reaction directions were estimated by using flux 
variability analysis (Mahadevan & Schilling, 2003). The steady-state model was constrained using 
glucose anaerobic growth physiological data (Fendt et al, 2010) (Supplementary Table 4.1). The 
resulting linear programming problem was solved using the glpk 
(http://www.gnu.org/software/glpk/) solver accessed through a C library. Reversible and non-
feasible reactions were removed, leaving producing and consuming reactions. For reactions catalyzed 
by isoenzymes, we used the average fold changes of the enzyme-coding transcripts, while for 
complexes, we used the transcript with the lowest fold change. Applying these criteria, each reaction 
was assigned a single fold-change value (see Chapter 3, Figure 3.1B). For each pair of producing and 
consuming genes/reactions, the Spearman’s rank correlation coefficient ρ was calculated for the fold 
changes from each comparison. Additionally, for each comparison, we took the average of all the 
producing genes and the average for all the consuming genes and calculated the Spearman’s rank 
correlation coefficient. Calculations were performed using the statistical software R (www.r-
project.org).  
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Supplementary Figure 4.1 Metabolite co-regulation patterns in yeast metabolic network. Panels are arbitrarily ordered, black dots 
represents individual input vs. output pair correlations; red dots represent the correlation of the average of input vs. average of 
output reactions. 
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Supplementary Figure 4.1 (continued) Metabolite co-regulation patterns in yeast metabolic network. Panels are arbitrarily 
ordered, black dots represents individual input vs. output pair correlations; red dots represent the correlation of the average of 
input vs. average of output reactions. 
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Supplementary Table 4.1 Physiological data of yeast batch anaerobic exponential growth (Fendt et al, 2010). Comma-separated 
values denote lower and upper bounds used for constraining the corresponding fluxes.  
Reaction (mmol/g/h) WT 
Glucose uptake 16.15, 17.85 
Ethanol secretion rate 20, 22 
Glycerol secretion rate 2, 2.2 
Acetate secretion rate 0.75, 1.51 
Pyruvate secretion rate 0.06, 0.09 
Growth rate 0.3, 0.33 
 
  
 
 
 
 
 
 
 
 
 
Der Mensch ist, was er ißt.* 
–Ludwig Andreas Feuerbach, 1863 
 
                                                          
*
 Translation from German: the man is what he eats 
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Chapter 5  
Metabolic network topology reveals transcriptional regulatory 
signatures of type 2 diabetes 
Abstract* 
Type 2 diabetes mellitus (T2DM) is a disorder characterized by both insulin resistance and impaired 
insulin secretion. Recent transcriptomics studies related to T2DM have revealed changes in 
expression of a large number of metabolic genes in a variety of tissues. Identification of the 
molecular mechanisms underlying these transcriptional changes and their impact on the cellular 
metabolic phenotype is a challenging task due to the complexity of transcriptional regulation and the 
highly interconnected nature of the metabolic network. In this study we integrate skeletal muscle 
gene expression datasets with human metabolic network reconstructions to identify key metabolic 
regulatory features of T2DM. These features include reporter metabolites – metabolites with 
significant collective transcriptional response in the associated enzyme-coding genes, and 
transcription factors with significant enrichment of binding sites in the promoter regions of these 
genes. In addition to metabolites from TCA cycle, oxidative phosphorylation, and lipid metabolism 
(known to be associated with T2DM), we identified several reporter metabolites representing novel 
biomarker candidates. For example, the highly connected metabolites NAD+/NADH and ATP/ADP 
were also identified as reporter metabolites that are potentially contributing to the widespread gene 
expression changes observed in T2DM. An algorithm based on the analysis of the promoter regions 
of the genes associated with reporter metabolites revealed a transcription factor regulatory network 
connecting several parts of metabolism. The identified transcription factors include members of the 
CREB, NRF1 and PPAR family, among others, and represent regulatory targets for further 
experimental analysis. Overall, our results provide a holistic picture of key metabolic and regulatory 
nodes potentially involved in the pathogenesis of T2DM. 
                                                          
*
 Published as: Zelezniak A, Pers TH, Soares SP, Patti ME, Patil KR. Metabolic Network Topology Reveals 
Transcriptional Regulatory Signatures of Type 2 Diabetes. PLoS Computational Biology, Vol. 6, No. 4, 2010, p. 
e1000729 
Chapter 5: Metabolic signatures of type 2 diabetes 
 
62 
Introduction 
Type 2 diabetes mellitus (T2DM) is emerging as one of the main threats to human health in the 21st 
century with an estimated 300 million individuals with T2DM by the year 2025 (Simpson et al, 2003; 
Zimmet et al, 2001). T2DM is characterized by both insulin resistance, as manifested by reduced 
insulin-stimulated glucose uptake in skeletal muscle and adipose tissue and inappropriately high 
hepatic glucose output (Pehling et al, 1984; Shulman, 2000), and reduced insulin secretion by 
pancreatic β-cells (Muoio & Newgard, 2008; Shulman, 2000). Although the specific molecular 
pathophysiology remains unclear, many risk factors have been identified for T2DM, including family 
history of diabetes and prominent environmental factors such as alterations in early life 
development, excessive food intake, obesity, decreased physical activity and aging (Muoio & 
Newgard, 2008; Shulman, 2000; Simpson et al, 2003). At the cellular level, multiple regulatory 
mechanisms and metabolic pathways may contribute to the pathogenesis of insulin resistance, 
potentially mediated by alterations in insulin signaling (Saltiel & Kahn, 2001), mitochondrial oxidative 
metabolism and ATP production (Kelley et al, 2002; Mootha et al, 2003; Patti et al, 2003), fatty acid 
oxidation (Boden, 1996), or proinflammatory signaling (Ueki et al, 2004). Similarly, alterations in β-
cell development and metabolism (Muoio & Newgard, 2008) may contribute to decreased insulin 
secretion. 
Available human tissue transcriptome data related to T2DM (Sreekumar et al, 2002; Yang et al, 
2002b) provide an opportunity for identification of novel molecular mechanisms underlying the 
metabolic phenotype of T2DM. This task is challenging due to the need to account for the inherent 
high connectivity of bio-molecular interaction networks. We have utilized a network-centered 
methodology to link diabetes-related alterations in gene expression to metabolic hot spots and 
transcription factors potentially responsible for gene expression changes. 
Rationale and Methodology 
Metabolic phenotypes at a cellular level are essentially characterized by concentrations of 
metabolites and fluxes through the reactions that make up the metabolic network. Fluxes, in turn, 
are dependent on metabolite levels, enzyme activities, abundance of effectors and possibly other 
variables. Measurement of fluxes and metabolite concentrations at the entire metabolic network-
scale is, however, a difficult task in humans due to a variety of technological and experimental 
limitations. By contrast, methods for measurement of expression of genes encoding metabolic 
enzymes are relatively well-established. Thus, the primary goal of this study is to use informatics 
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approaches to integrate available gene expression data with metabolic networks, in order to predict 
metabolic phenotypes of skeletal muscle linked to the pathogenesis of type 2 diabetes. Such an 
approach will help not only to gain insight into the organization of transcriptional regulation in 
human tissues, but also provide guidance for improved design of experimental strategies for 
obtaining metabolite and flux data, which can be further integrated into metabolic models. 
To achieve these goals, we applied an extension of the algorithm described in (Patil & Nielsen, 2005) 
(for various applications of this algorithm see (Baxter et al, 2007; Capel et al, 2009; David et al, 2006; 
Patil & Nielsen, 2005; Seggewiss et al, 2006)), which enables identification of so-called reporter 
metabolites, or metabolic hot spots around which transcriptional regulation is centered (Figure 5.1A, 
Supporting text S). This analysis is based on the assumption that under most conditions of 
physiological interest, fluxes through enzymes connected to a metabolite are coordinated in order to 
maintain physiological homeostasis, or to eventually reach a new (pseudo-) steady-state. Moreover, 
transcriptional regulation of expression of genes encoding critical enzymes in metabolic flux 
pathways facilitates concordance with the metabolic demands of the cell and corresponding 
stoichiometric and thermodynamic constraints on fluxes. For this analysis, we applied two recently 
published human metabolic network models: i) Homo sapiens Recon1 (Duarte et al, 2007), and ii) 
Edinburgh Human Metabolic Network (EHMN) (Ma et al, 2007). 
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Figure 5.1 Schematic overview of the methodology used for the identification of reporter metabolites and associated 
putative regulatory sequence motifs. A) Scoring system for identification of reporter metabolites. Each metabolite is scored 
based on the scores of the associated enzyme-catalyzed reactions. Each enzyme, in turn, is assigned a score based on 
median of the P-values of the probes representing the corresponding gene. In case of a reaction catalyzed by an enzyme 
complex or a set of isozymes, minimum of the P-values of the corresponding enzymes is chosen. Numbers in bold are Z-
scores for each reaction, the rest of the numbers represent P-values (significance of differential expression). B) 
Identification of transcription factor binding motifs. For a reporter metabolite, a set of up/down regulated neighbor 
(enzyme-coding) genes is selected. Promoter regions, upstream of transcription start site (TSS) of each of the selected 
genes are assessed for the enrichment of known transcription factor (TF) binding sequence motifs. 
We further hypothesized that the observed coordinated changes around reporter metabolites can 
be, at least in some cases, attributed to common transcriptional regulatory mechanisms. Specifically, 
we hypothesize that the neighbor enzymes of reporter metabolites may share one or more 
transcription factor binding sites in the promoter regions of the corresponding genes. In order to 
identify such potential regulatory players, we tested promoter sequences of the genes associated 
with the reporter metabolites for enrichment of known transcription factor binding motifs (Figure 
5.1B). Transcription factors identified in this fashion provide clues to the regulatory mechanisms that 
lead to observed gene expression changes in the metabolic network. 
Since our goal is to identify reporter metabolites and transcription factors potentially involved in 
diabetes pathogenesis and progression we analyzed two independent studies of skeletal muscle 
transcriptomics in individuals with established type 2 diabetes or insulin resistance (Mootha et al, 
2003; Patti et al, 2003) (Supporting Text 1), In the first study (Mootha et al, 2003), biopsies were 
obtained following insulin stimulation from a cohort of 43 Swedish men of Caucasian ethnicity with a 
spectrum of glucose tolerance, including 17 with normal glucose tolerance (NGT), 8 with impaired 
glucose tolerance (IGT), and 18 with established T2DM. The second dataset (Patti et al, 2003) was 
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derived from a cohort of 15 subjects of Mexican American ethnicity, in whom muscle biopsies were 
performed in the fasting state. Importantly, this cohort included individuals with not only established 
diabetes (5 subjects, T2DM), but also individuals with completely normal glucose tolerance but a 
spectrum of insulin resistance; normal glucose tolerant subjects were subdivided by family history-
linked diabetes risk (4 family history positive, more insulin resistant subjects, FH+; and 6 family 
history negative, more insulin sensitive subjects, FH-). With this approach, the individual 
contributions of isolated insulin resistance and diabetes risk (in the setting of normoglycemia, FH+), 
mild elevations in postprandial glucose (IGT), and established diabetes can be individually assessed. 
Moreover, the possible contribution of family history, potentially mediated by genetics or shared 
environment, can be assessed. Thus, we predict that analysis of the common patterns resulting from 
the two datasets will identify regulatory signatures potentially independent of study cohort and 
design variation but common to the pathophysiology of insulin resistance and diabetes. 
Results 
In present study, we performed reporter metabolite analysis based on pair-wise comparisons within 
each dataset; differential expression and its significance were assessed with robust multi-array 
average (RMA) and empirical Bayes testing. Significance of differential expression for each gene was 
used as a scoring metric (Materials and Methods). The results are summarized as metabolic 
signatures (reporter metabolites) and regulatory signatures (transcription factors) for T2DM. 
Metabolic signatures of T2DM 
Swedish male dataset 
Reporter metabolite analysis for three pair-wise comparisons, viz., T2DM vs. NGT, T2DM vs. IGT, and 
IGT vs. NGT, revealed significant reporter metabolites (P-value ≤ 0.05) participating in lipid 
metabolism, TCA cycle, oxidative phosphorylation (OXPHOS) and glycolysis (Table 5.1, Table 5.2, 
Table S1† and Table S2). Among reporter metabolites identified for the T2DM vs. NGT comparison 
were lipid species 1,2-diacyl-sn-glycerol (DAG), acetoacetyl-CoA, and the sphingolipid sphinganine. 
These are interesting as prior studies (Holland et al, 2007; Roden, 2005; Savage et al, 2007; Shulman, 
2000) have demonstrated that the related lipid molecules diacylglycerols (DAG), long-chain fatty acyl 
CoAs, and ceramides correlate positively with triglyceride content and inversely with insulin 
sensitivity (Muoio & Newgard, 2008) and have been shown to induce insulin resistance (Shulman, 
                                                          
†
 Supplementary tables S1-S8 together with Figure S1 for this chapter can be accessed through the web: 
http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1000729#s5 
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2000). Furthermore, given that saturated fatty acids appear to play a particularly important 
pathogenic role in insulin resistance (Salek et al, 2007), it is interesting that several metabolites of 
saturated fatty acids (such as hexanoyl-CoA, palmitoyl-CoA, tetradecanoyl-CoA, lauroyl-CoA, 
decanoyl-CoA and butanoyl-CoA) were found as reporter metabolites with mostly up-regulated 
neighboring genes in the IGT vs. NGT comparison (Table 5.1 and Table S2), and thus may serve as 
potential markers of insulin resistance and IGT. 
TCA cycle metabolites citrate and 2-oxoglutarate, with down-regulated neighboring genes, were also 
uncovered as reporter metabolites in the T2DM vs. NGT comparison (Table 5.1, Table S1, Table S2). 
These results are concordant with a study of human urine metabolome profiles from patients with 
T2DM (Salek et al., 2007), in which levels of citrate and 2-oxoglutarate were lower in T2DM 
compared to healthy controls (Newgard et al, 2009). Among other mitochondrial metabolites, 
reduced and oxidized forms of cytochrome c and ubiquinol were identified as reporter metabolites 
(T2DM vs. NGT, Table S1) with down-regulated expression of the associated genes.  
Impaired glucose tolerance typically reflects an important transition between normoglycemia and 
overt diabetes, reporter metabolites which are identified in both IGT vs. NGT and T2DM vs. NGT, but 
not significantly different in the T2DM vs. IGT comparison (e.g. phosphatidylethanolamine, 2-
hydroxyglutarate, 2-oxoglutarate, 3',5'-cyclic AMP, ATP, Table S1, Table S2) may be considered novel 
biomarkers of early-stage glucose intolerance. 
Mexican-American dataset  
We similarly performed reporter metabolite analysis using both Recon1 and EHMN metabolic models 
in the Mexican-American dataset. This analysis revealed significant transcriptional regulation in 
metabolite nodes in TCA cycle, oxidative phosphorylation, and lipid metabolism, for both T2DM vs. 
FH- and FH+ vs. FH- comparisons (Patti et al, 2003). Similar to the Swedish Caucasian dataset, 
metabolites involved in oxidative phosphorylation (e.g. ferrocytochrome c, H+, and fumarate) were 
among the top-ranking reporter metabolites, identified in both the T2DM vs. FH- and FH+ vs. FH- 
comparisons (Table 5.2, Table S3). Interestingly, urinary levels of fumarate, an important link 
between the TCA cycle and oxidative phosphorylation, were recently found to be decreased in T2DM 
patients (Salek et al, 2007). 
Analysis using the EHMN model revealed TCA cycle-related metabolites, including 3-carboxy-1-
hydroxypropyl-ThPP, aconitate, succinyl-CoA, malate and fumarate, as significant reporter 
metabolites (P-value ≤ 0.05), with mostly down-regulated expression of the genes encoding their 
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neighboring enzymes. Ubiquinol was found as reporter metabolite representative of electron 
transfer chain. Several molecules within β-oxidation pathways, such as 3-cis-dodecenoyl-CoA, 
glutaryl-CoA, trans-3-decenoyl-CoA, 3-methylbutanoyl-CoA and 3-methylcrotonyl-CoA, as well as in 
amino acid (leucine, lysine) metabolism were also identified as reporters (Table 5.2, Table S4). 
Moreover, glutamate, glycerol derivatives, phosphocreatine, a number of hormone derivatives and 
many others (Table S3 and Table S4) were found as significant reporter metabolites in the T2DM vs. 
FH- comparison.  
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Table 5.1 Reporter metabolites for Swedish male dataset.  
Reporter Metabolite P-values  
Enzyme neighbors 
(Up-regulated : 
Down-regulated)   
 T2DM/NGT IGT/NGT T2DM/NGT IGT/NGT  
Citrate  0.047 0.646 1:0 1:0 TCA cycle 
Succinyl-CoA 0.013 0.285 2:3 2:3  
2-Hydroxyglutarate
*
 0.002 0.023 0:1 0:1  
2-Oxoglutarate
*
 0.049 0.047 8:11 8:11  
Ferrocytochrome C; Ferricytochrome C 0.006 0.032 1:2 0:3 OXPHOS 
Ubiquinone-10 0.017 0.769 0:5 1:4  
Ubiquinol-10 0.022 0.484 0:4 1:3  
Phosphoenolpyruvate
*
 0.196 0.037 1:3 1:3 Glycolysis 
D-Glyceraldehyde
*
 0.083 0.017 2:1 3:0  
D-Alanine 0.016 0.330 0:3 0:3 A. a. metabolism 
L-Alanine 0.047 0.319 3:7 3:7  
3-Methylglutaconyl-CoA
†
 0.038 0.816 0:2 1:1  
L-Leucine
*
 0.047 0.109 1:3 1:3  
1,2-Diacyl-sn-glycerol (DAG)
*
 0.022 0.049 2:5 2:5 Lipid metabolism 
1D-myo-Inositol 1,4-bisphosphate
†
 0.060 0.151 0:3 2:1  
3-Dehydrosphinganine
*
 0.232 0.035 1:1 2:0  
Acetoacetyl-CoA
*
 0.009 0.462 1:4 2:3  
Butanoyl-CoA
†
 0.365 0.038 0:2 1:1  
Decanoyl-CoA; Lauroyl-CoA
*
 0.268 0.033 1:2 2:1  
Fatty acid
*
 0.021 0.756 3:4 3:4  
Lophenol
*§
 0.007 0.749 0:1 0:1  
Palmitoleoyl-CoA
*
 0.238 0.019 1:3 2:2  
Palmitoyl-CoA
*
 0.179 0.014 3:4 6:1  
Phosphatidyl glycerol phosphate  0.047 0.316 0:1 0:1  
Phosphatidylinositol 4,5-bisphosphate  0.097 0.001 1:5 2:4  
Propanoyl-CoA
*
 0.259 0.016 2:5 2:5  
Prostaglandin E2 0.036 0.032 0:3 1:2  
Sphinganine
*
 0.038 0.283 1:3 2:2  
(Gal)3 (GalNAc)1 (Glc)1 (Cer)1
*
 0.023 0.034 1:2 1:2 Other 
AMP
†
 0.041 0.218 7:17 6:17  
ATP
†
 0.003 0.010 28:60 27:60  
cAMP
†
 0.033 0.049 2:0 2:0  
CDPcholine 0.020 0.122 0:2 0:2  
Choline phosphate 0.030 0.573 0:2 1:1  
NAD+
*
 0.333 0.020 29:34 34:34  
Phosphocreatine 0.025 0.176 0:1 1:0  
Trichloroethanol
*
 0.020 0.038 1:2 3:0  
*Reporter metabolites identified using EHMN metabolic network. †Reporter metabolites identified in both networks. 
§ lant metabolite, likely to be present in the EHMN due to incorrect annotation. Reporter metabolites with p ≤ 0.05 in at 
least one of the comparisons showed in bold. Columns with enzyme neighbors show the number of up- and down-
regulated enzyme neighbors in the first condition (e.g. T2DM/NGT up- and down-regulated in T2DM comparing with NGT) 
for each of comparisons. Reporter metabolites without marks were identified using Recon1 metabolic network. Metabolites 
written in italics are known to be directly/indirectly related to T2DM, see main text and Table S8. A.a. – amino acid; 
OXPHOS – oxidative phosphorylation. 
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Table 5.2 Reporter metabolites for Mexican-American dataset. 
Reporter metabolite  P-values  
Enzyme neighbors 
(Up-regulated : 
Down-regulated)   
 T2DM/FH- FH+/FH- T2DM/FH- FH+/FH-  
2-Oxoglutarate 0.001 0.001 2:7 2:7 TCA cycle 
L-Malate 0.098 0.029 1:4 2:3  
Succinyl-CoA
†
 0.011 0.009 0:5 0:5  
Ferrocytochrome C;Ferricytochrome C 0.008 0.007 0:3 0:3 OXPHOS 
Fumarate 0.019 0.025 0:2 0:2  
Ubiquinone-10
†
;Ubiquinol-10
†
 0.040 0.021 1:3 1:3  
2,3-Disphospho-D-glycerate
†
 0.021 0.004 0:1 0:1 Glycolysis 
2-Phospho-D-glycerate
*
 0.038 0.006 0:2 1:1  
beta-D-Fructose
*
 0.049 0.038 0:2 0:2  
D-Fructose 2,6-bisphosphate 0.037 0.136 0:2 0:1  
D-Fructose 6-phosphate 0.013 0.119 4:6 3:7  
D-Glucose
*
 0.037 0.066 0:7 1:5  
D-Glucose 6-phosphate 0.009 0.014 1:3 1:3  
D-Glycerate 2-phosphate 0.026 0.003 0:2 1:1  
L-Lactate 0.048 0.067 1:2 1:2  
Phosphoenolpyruvate 0.079 0.048 2:2 3:1  
Pyruvate 0.042 0.202 1:6 1:6  
2-Oxoadipate
*
 0.002 0.004 0:1 0:1 A. a. metabolism 
beta-Alanine 0.031 0.027 1:1 1:1  
L-Glutamate
†
 0.025 0.009 1:1 1:1  
(R)-2-Methyl-3-oxopropanoyl-CoA
*
 0.043 0.118 0:2 0:1 Lipid metabolism 
1,2-Diacyl-sn-glycerol (DAG)
*
 0.036 0.117 3:2 5:1  
1D-myo-Inositol 1,4-bisphosphate 0.025 0.054 1:2 1:2  
3-cis-Dodecenoyl-CoA
*
 0.009 0.039 0:3 0:3  
Acylglycerol
*
; 2-Acylglycerol
*
 0.035 0.018 1:1 1:1  
Glutaryl-CoA
†
 0.007 0.015 0:2 0:2  
Glycerol 0.020 0.001 1:1 1:1  
Glycerol 3-phosphate 0.051 0.005 2:1 2:1  
Lipoamide
*
 0.014 0.006 0:5 0:5  
Phosphatidylinositol  0.017 0.128 1:5 1:5  
trans-3-decenoyl-CoA
*
 0.026 0.076 0:2 0:2  
ADP 0.047 0.174 16:31 20:27 Other 
CO2 0.041 0.004 1:11 3:9  
Coenzyme A
†
 0.007 0.014 4:8 3 10  
Creatine;Phosphocreatine
†
 0.032 0.048 0:1 0:1  
NAD+
†
; NADH
†
 0.003 0.095 3:17 17:4  
Trichloroethanol
*
 0.021 0.006 2:1 3:0  
*
Reporter metabolites identified using EHMN metabolic network. 
†
Reporter metabolites identified in both networks. 
Reporter metabolites with p ≤ 0.05 in at least one of the comparisons showed in bold. Columns with enzyme neighbors 
show the number of up- and down-regulated enzyme neighbors in the first condition (e.g. T2DM/FH- up- and down-
regulated in T2DM comparing with FH-). Reporter metabolites without marks were identified using Recon1 metabolic 
network. Metabolites written in italics are known to be directly/indirectly related to T2DM, see main text and Table S8. A.a. 
– amino acid; OXPHOS – oxidative phosphorylation. 
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Overlapping reporter metabolites between two study populations 
In order to determine the extent of overlap between the two study populations, we performed a 
cluster analysis of the pair-wise comparisons within the Swedish and Mexican-American datasets 
(Figure 5.2). Jaccard distance metric between two pair-wise comparisons (e.g. T2DM vs. FH- and FH+ 
vs. FH-) was calculated based on the overlap of reporter metabolites between the two comparisons. 
Jaccard distance provides a measure of dissimilarity between two sets of reporter metabolites, and is 
quantified as the fraction of non-overlapping reporter metabolites between the two sets. While 
similar clustering patterns were observed (Figure 5.2A and Figure S1A) independent of the use of 
either EHMN or Recon1 metabolic model, Swedish and Mexican-American studies clustered 
separately, perhaps related to differences in study population, study design (e.g. fasting studies in 
Mexican-Americans, insulin-stimulated studies in Swedish) or differences in microarrays used (thus 
differing in the coverage of metabolic enzymes). We observed substantial overlap between the 
T2DM vs. FH- and FH+ vs. FH- comparisons, suggesting that insulin resistance patterns could 
contribute to these findings (Table S5, Table S6). 
 
Figure 5.2 Hierarchical clustering of pair-wise comparisons within the Swedish male and Mexican-American datasets based 
on the overlapping reporter metabolites (Recon1 model). Comparisons are colored according to the dataset; blue – 
Mexican-American; orange – Swedish male dataset. A) Dendrogram of reporter metabolites identified in each of the 
comparisons based on Jaccard distance. B) Venn diagram showing the overlap of the reporter metabolites identified in the 
different comparisons. 
We next examined the overlap of reporter metabolites between the two case studies (Figure 5.2B 
and Figure S1B). Owing to differences in the metabolite-gene connectivity between EHMN and 
Recon1, the number of overlapping reporter metabolites is generally higher for the EHMN analysis. 
To a large extent, this difference is due to the groups of metabolites in EHMN that share the same 
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gene neighbors (whether two metabolites share the same gene neighbors depends not only on the 
network used, i.e. number of distinct biochemical reactions associated with a particular enzyme, but 
also on the coverage of genes on the particular microarray chip used). In addition to many other 
metabolites, phosphocreatine appeared as a significant reporter in both case studies, viz., for T2DM 
vs. NGT and T2DM vs. FH- comparisons. Phosphocreatine is an important energy reservoir metabolite 
in skeletal muscle, and defects in recovery of phosphocreatine have been identified in vivo in humans 
with insulin resistance (Fleischman et al, 2009) and diabetes (Phielix et al, 2008). Interestingly, low 
levels of urinary creatine have also been found in patients with T2DM (Salek et al, 2007).  
Regulatory signatures of T2DM 
In order to link the identified reporter metabolites to regulatory pathways controlling gene 
expression, we hypothesized that enzymes associated with reporter metabolites would be regulated 
by common transcription factors. As potential candidates subjected to such regulation we selected 
all reporter metabolites with at least 5 up- or down-regulated neighboring genes (Materials and 
Methods). Up- and down-regulated gene sets were then analyzed separately in order to assess 
whether their promoter regions were enriched for known transcription factor binding sequence 
motifs. P-values for enrichment were estimated by using a hyper-geometric test, which compared 
the proportion of promoters from a given gene set containing a particular motif with the frequency 
of occurrence of that motif in promoter regions of all other metabolic genes. Correction for multiple-
testing was done by using q-value (Storey & Tibshirani, 2003) and motifs with q-value ≤ 0.05 were 
considered as significantly enriched. 
In accord with our hypothesis, several transcription factor binding sites were overrepresented in the 
promoter regions of the enzymes associated with reporter metabolites. A summary of the main 
results from this analysis is illustrated in Figure 5.3A. Many transcription factors were found to be 
common across the two case studies (Figure 5.3B), albeit in connection with different reporter 
metabolites. PPAR family motifs (PPARγ and PPARα:RXRα) were enriched in seven downregulated 
enzyme sets including ATP. Tax/CREB motifs were enriched in promoters of downregulated enzymes 
associated with ATP, ADP and phosphate. Additional down-regulated neighbors of ATP were enriched 
for the binding sites of NF-κB, MEF-2, UF1-H3β, Pax-9 and NKX6.2, while the NRF-1 motif was 
enriched in the set of up-regulated enzymes neighboring ADP. Another potential regulatory signature 
was identified around the down-regulated neighbors of phosphatidylinositol and 
phosphatidylinositol 4,5-bisphospate (important phospholipids which participate in insulin and other 
signaling reactions), which were significantly enriched for binding sites of p53, PPARγ, SRF, SEF-1, v-
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Jun, GCNF, AR and many others (Table S7). These and other highly connected reporter metabolites in 
the metabolite-TF network (Figure 5.3A) demonstrate the concept that associated metabolic 
pathways can be transcriptionally regulated in multiple ways in response to environmental stimuli or 
metabolic perturbation. 
 
Figure 5.3 Summary of the main results from the motif enrichment analysis. A) Motif enrichment analysis for the genes 
associated with reporter metabolites from the T2DM vs. NGT comparison. Reporter metabolites with up-regulated 
neighboring gene set are shown as red circles, whereas reporter metabolites with down-regulated neighboring gene set are 
represented as green circles. Transcription factor binding motifs (shown as triangles) are colored according to the number 
of enzyme sets in which they are enriched, ranging from light yellow (enriched in few sets) to orange (enriched in as many 
as 6 sets). Edges are scaled according to q-values signifying the confidence of the motif enrichment. B) Venn diagram 
showing the overlap of transcription factor binding motifs across the comparisons of T2DM with non-T2DM cases. 
Comparisons are colored according to the dataset; blue – Mexican-American; orange – Swedish male dataset. 
Discussion 
Maintenance of whole-body glucose metabolism is reliant on a delicately balanced dynamic 
interaction between tissue sensitivity to insulin (including muscle, adipose and liver) and insulin 
secretion (Bajaj & Defronzo; Muoio & Newgard, 2008). Unfortunately, the molecular mechanisms 
responsible for diabetes risk remain unknown. A key metabolic phenotype associated with insulin 
resistance in humans is inappropriate lipid accumulation in tissues outside of adipose tissue, 
suggesting defects in fatty acid uptake, synthesis, and/or oxidation. With lipid excess and/or impaired 
oxidation, as observed in obesity and/or inactivity, flux of long-chain acyl CoAs (LC-CoA) may be 
redirected into cytosolic lipid species such as diacylglycerols (DAG), triacylglycerols (TG) and 
ceramides (derivatives of sphingosine and fatty acid metabolism) (Muoio & Newgard, 2008) that are 
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correlated with reductions in insulin signaling and insulin resistance (Holland et al, 2007; Itani et al, 
2002; Roden, 2005; Savage et al, 2007; Shulman, 2000). Whether alterations in mitochondrial 
oxidative function in humans with insulin resistance and diabetes contribute to, or are a 
consequence of these defects, remains unclear (Patti & Corvera, 2010). 
Recognizing these important gaps in our knowledge of diabetes pathophysiology, we have integrated 
transcriptomic data with metabolic networks to systematically identify, in an unbiased fashion, 
regulatory hot spots (reporter metabolites and associated transcription factors) associated with 
insulin resistance and T2DM. Our reporter metabolite results provide evidence for transcriptional 
dysregulation of multiple metabolic pathways in skeletal muscle. Interestingly, many of the reporter 
metabolites identified in our analysis have been appreciated in prior experimental studies in animal 
models (metabolites with italic font in Table 5.1, Table 5.2 and Table S8). A bird’s-eye view of 
selected metabolic and regulatory nodes identified in our study, integrated with selected key cellular 
pathways, is depicted in Figure 5.4, and key regulatory nodes potentially contributing to diabetes-
associated pathophysiology are discussed in more detail below. 
Key metabolic regulatory nodes in T2DM pathogenesis 
Lipid metabolism 
In conditions of overnutrition and physical inactivity, availability of cellular fatty acids stimulate 
ligand–dependent PPARα/δ transcription factors which, in turn, induce transcription of genes 
responsible for β-oxidation (Kersten et al, 2000; Koves et al, 2005). Metabolic byproducts of 
incomplete β-oxidation, such as acylcarnitines and reactive oxygen species, may accumulate in 
mitochondria and contribute to insulin resistance (Muoio & Newgard, 2008). Interestingly, our 
analysis identified enrichment of PPAR family transcription factor binding motifs in T2DM as 
compared with insulin sensitive subjects, in both the Swedish and Mexican-American datasets (T2DM 
vs. NGT and T2DM vs. FH-, respectively). Moreover, reporter analysis revealed lipid metabolites 
(Table S1), known to be natural ligands of PPARγ (prostaglandins) (Kersten et al, 2000). 
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Figure 5.4 Metabolic and regulatory signatures of type 2 diabetes. Key metabolic and regulatory pathways associated with 
reporter metabolites identified in this study (T2DM vs. NGT and T2DM vs. FH- comparisons) are shown. Metabolites in bold 
black font are reporter metabolites. Grey shapes and arrows represent facts/hypotheses from previous studies and are not 
directly based on the results from the present study. Broken lines imply indirect effect while full lines denote direct effect. 
Chronic overfeeding and physical inactivity increase the influx of fatty acid, which promotes β-oxidation through the 
activation of PPARα/δ-mediated genes, without coordinated increase in TCA cycle flux. Reporter analysis supports this idea 
by showing the decreased activity in TCA cycle enzymes associated with reporter metabolites. Eventually, this leads to 
mitochondrial accumulation of metabolic by-products of incomplete β-oxidation (acylcarnitines ROS). These stresses might 
lead to mitochondrial overload which together with intracellular lipid-signaling (such as DAG) molecules might trigger serine 
a serine/threonine (Ser/Thr) kinase (Ser/Thr) cascade initiated by nPKCs. As a result, Ser/Thr phosphorylation of insulin 
receptor substrate 1 (IRS-1) sites is induced, thereby inhibiting IRS-1 tyrosine phosphorylation and activation of PI 3-kinase, 
resulting in impeded GLUT4 translocation, reduced glucose transpor, and decreased glycogen synthesis. Increased physical 
activity/fasting activates PGC1α and CREB (a potent inducer of PGC-1α). These actions combat lipid stress by increasing TCA 
cycle flux and by coupling ligand-induced PPARα/δ activity with PGC1α-mediated remodeling of downstream metabolic 
pathways such as respiration and β-oxidation. CDP-choline, cytidine diphosphate choline; DAG, diacylglycerol; G1P, glucose 
1-phosphate; G6P, glucose 6-phosphate; GLUT4, glucose transporter-4; GSK3, glycogen synthase kinase-3; IRE1, inositol 
requiring kinase-1; LC-CoAs, long-chain acyl CoAs; nPKCs, novel protein kinase Cs; PA, phosphatidate; PGC1α, PPARγ co-
activator-1α; PH, pleckstrin homology domain;PI, phospatidylinositol; PIP, phospatidylinositol 4-phospate; PIP2, 
phosphatidylinositol 4,5-bisphospate, PIP3, phospatidylinositol 3,4,5-trisphospate; PI 3-kinase, phosphoinositol 3-kinase; 
PPARγ, peroxisome proliferator-activated receptor-γ; PTB, phosphotyrosine binding domain; ROS, reactive oxygen species; 
RXR, retinoid X receptor; SH2, src homology domain; TCA, tricarboxylic acid cycle; TF, transcription factor; CPT1, carnitine 
palmitoyltransferase-1; PTDETN, phosphatidylethanolamine. 
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Another reporter metabolite identified in our analysis is diacylglycerol (DAG), a lipid signaling 
molecule known to inversely correlate with insulin sensitivity (Holland et al, 2007; Itani et al, 2002; 
Roden, 2005; Savage et al, 2007; Shulman, 2000). Our results suggest that perturbations in DAG 
levels may be accompanied by changes in the adjacent CDP-Choline branch of the Kennedy pathway 
of phospholipid metabolism (Figure 5.4). Thus, DAG could potentially affect insulin sensitivity via 
activation of serine/threonine kinases or alterations in phospholipid membrane composition, both of 
which could lead to defects in insulin signaling, reduced insulin-stimulated glucose uptake, and 
glycogen synthesis- key metabolic features of diabetes (Muoio & Newgard, 2008) (Figure 5.4). 
Together, identification of these lipid-linked regulatory motifs and reporter metabolites known to be 
involved in type 2 diabetes pathogenesis provides further support for the validity of our approach. 
Central carbon metabolism 
Using our approach we found several reporter metabolites from the TCA cycle (citrate, 2-
oxoglutarate, succinyl-CoA, fumarate and malate) (Figure 5.4). The down-regulated genes associated 
with these metabolites support the idea that TCA cycle and/or oxidative phosphorylation flux is 
reduced in diabetes (Patti et al, 2003). It is also interesting that ATP is one of the reporter 
metabolites, as the majority of cellular ATP is generated via respiration. Moreover, significant 
enrichment of binding motif for NF-κβ in the upregulated ATP neighbors is consistent with the 
potential role of this transcription factor in mediating oxidative stress responses triggered by by-
products of incomplete β-oxidation (Sen & Packer, 1996). Another interesting finding is the 
enrichment of CREB family and NRF-1 motifs in enzymes associated with ATP and ADP. These results 
corroborate the role of CREB as an indirect regulator of nuclear-encoded oxidative phosphorylation 
genes via PGC1- and other regulators linked to nuclear-encoded mitochondrial genes (Figure 5.4) 
(Patti et al, 2003; Scarpulla, 2006; Scarpulla, 2008). 
The appearance of highly connected metabolites, such as ATP and NADH, among top-ranking 
reporter metabolites provides a possible link to the observed network-wide transcriptional changes 
in IGT and T2DM. Cellular levels of these co-factors are usually constrained within relatively narrow 
ranges to maintain thermodynamic stability. Oxidative phsophorylation, which is connected to TCA 
cycle flux via succinate and fumarate, accounts for most of the ATP (and NADH) turnover in a 
respiring cell. Our results suggest reduction in the activity of both TCA cycle and oxidative 
phosphorylation, in agreement with recent NMR data demonstrating that mitochondrial ATP 
synthesis is reduced in humans with insulin resistance (Petersen et al, 2003; Petersen et al, 2005; 
Szendroedi et al, 2007). Another major source of ATP and NADH production in the cell is glycolysis. 
Chapter 5: Metabolic signatures of type 2 diabetes 
 
76 
Reporter metabolites representative of glycolysis (glucose, glucose-6-phosphate, glucose-1-
phosphate and pyruvate) also exhibited concordant down-regulation of the neighboring genes. 
The concordance between the changes in gene expression levels for glycolysis, TCA cycle and 
oxidative phosphorylation in IGT and T2DM suggests that transcriptional regulatory mechanisms may 
be a response to altered levels of ATP/NADH. Such response may achieve two purposes: i) regulation 
of metabolism on global scale, as these co-factors are critical components of many metabolic 
pathways, and ii) regulation of NADH levels may help in reducing excessive (and potentially 
deleterious) oxidative stress resulting from sustained oxidation of excessive nutrients (Ristow et al, 
2009). Although the way such regulatory control is mechanistically linked to the corresponding 
metabolites cannot be deduced from the gene expression data alone, there are several examples 
where metabolite co-factors are directly involved in regulating gene expression, e.g. NADH(/+) 
dependent regulation of genes in gram-positive bacteria (Brekasis & Paget, 2003), yeast (Anderson et 
al, 2003; Lin et al, 2000; Zhang et al, 2002) and human (Agarwal & Auchus, 2005; Rutter et al, 2001). 
NAD+ dependent changes in gene expression levels could also be mediated by the action of PGC-1α 
and SIRT1 complex, which have important roles in regulation of glucose homeostasis (Rodgers et al, 
2005). Additional regulatory links, between glycolytic flux, energy metabolism, TCA cycle flux and 
fatty acid metabolism are also known in other eukaryotic systems such as baker’s yeast (Cimini et al, 
2009; Raghevendran et al, 2006; Schuurmans et al, 2008). Furthermore, several of the enzymes from 
central carbon metabolism may be regulated to a large extent at the post-transcriptional level 
(Daran-Lapujade et al, 2007; He et al, 2001). Parallels of such regulatory circuits in human cells may 
be discovered in the future with the here-identified transcription factors (Table S7) as one of the 
starting points. 
Other pathways 
Metabolites involved in protein and lipid glycosylation were found as reporters and characterized by 
down-regulation of neighboring enzymes (Table S2). Alterations in glycosylation may ultimately cause 
misfolding of several proteins, a feature previously associated with over-nutrition in hepatocytes 
(Shulman, 2000). Another reporter metabolite, shared by T2DM vs. NGT and T2DM vs. FH- 
comparison, is trichloroethanol, a metabolite in the cytochrome P450-mediated pathway derived 
from trichlorethene (Bruning et al, 1998). Although tricholoethanol or tricholoethene is not an 
endogenous metabolite in human tissues, it appears that the expression of the cytochrome P450 is 
altered in T2DM. Interestingly, experimental evidence shows that mouse exposure to trichlorethene 
leads to PPARα activation and the reprogramming of gene expression, resulting in induction of 
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enzymes mediating β- and ω-oxidation of fatty acids, and increased expression of genes involved in 
lipid metabolism (Laughter et al, 2004), a pattern similar to the T2DM metabolic phenotype 
(Shulman, 2000). 
Reporter metabolites and macroscopic physiological parameters  
The identification of reporter metabolites from glycolysis and energy-generation pathways suggests 
that there may be regulation of certain physiological parameters, such as glucose uptake, at the 
transcriptional level of the corresponding metabolic pathways. To investigate the extent of such 
possible regulation, we calculated Pearson correlation coefficients between insulin sensitivity (as 
measured by either whole-body glucose uptake during the hyperinsulinemic euglycemic clamp or 
insulin levels achieved during the OGTT) and mean centroid expression levels of genes surrounding 
reporter metabolites (Swedish dataset) (Materials and methods). A significant linear correlation with 
whole-body glucose uptake was observed for several reporter metabolites. In most cases, the 
correlation was significant only for one of the conditions (NGT, IGT or T2DM). For example, 
significant correlation of transcriptional regulation around dUDP with glucose uptake was found only 
for NGT samples (Figure 5.5A). It appears that this potential connection is de-linked under IGT and 
T2DM conditions. Another example is 1-Phosphatidyl-1D-myo-inositol 3-phosphate (Figure 5.5B), 
where significant correlation is observed with insulin level only for IGT. Further investigation of the 
causal mechanisms behind these observed correlation patterns may help in elucidating the 
regulatory role of the reporter metabolites in diabetes pathogenesis. 
Potential biomarkers and pharmacological targets 
A key scientific and clinical challenge is to identify molecular markers of diabetes risk, not only to 
better understand disease pathophysiology, but also to develop novel therapies for prevention and 
treatment of established diabetes. In this context, it is interesting that our analysis identified both 
PPARγ and its potential lipid ligands as regulatory molecules, since PPARγ ligand thiazolidinediones 
are currently employed as effective therapy for diabetes. We hypothesize that some transcriptional 
pathways identified in the current analysis, including CREB, NRF-1 and SRF, may be additional novel 
molecular mediators of the transcriptomic phenotype associated with insulin resistance, and thus 
potential targets for future intervention strategies. Of course, the potential roles of these pathways 
will require additional testing in cultured cells and animal models, where their impact on metabolic 
flux and insulin sensitivity can be fully assessed. 
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Figure 5.5. Correlation of glucose uptake and insulin level with mean centroid expression levels of reporter metabolite 
neighbor genes (Swedish male dataset). M value – whole-body glucose uptake during the hyperinsulinemic euglycemic 
clamp, Insulin 120 min – insulin levels achieved at the two hour time point of oral glucose tolerance test. 
Similarly, reporter metabolites identified in our analysis represent molecules likely to be involved in 
human skeletal muscle insulin resistance phenoytpes and also novel candidate biomarkers of insulin 
resistance and diabetes risk. In support of this hypothesis, several of the identified metabolites have 
known physiological roles in T2DM (Table S8 and Discussion above). Additional molecules have been 
analyzed either in rodents and/or in other tissues (Table S8) and thus, their appearance as reporter 
metabolites also strongly implicates their involvement in insulin resistance in human skeletal muscle. 
Some of the more novel metabolites identified in our analysis, including glycolytic and fatty acid 
oxidation intermediates, are known targets of metformin, a compound effective for diabetes therapy 
and prevention (Figure 5.4). We also identified an interesting link between DAG, a reporter 
metabolite for T2DM, and the CDP-Choline branch of the Kennedy pathway of phospholipid 
metabolism (Figure 5.4). This pathway has been implicated in cancer development and is being 
established as anti-tumor drug target (Banez-Coronel et al, 2008; Ramirez de Molina et al, 2005). 
Changes in phospholipid metabolism are also known to affect the properties of cellular membranes, 
and subsequently signaling through membrane proteins. Further investigation of the role of 
phospholipids in T2DM pathogenesis may provide clues to some of the missing links that connect 
metabolic flux changes with insulin signaling in skeletal muscle cells. 
Supplementary tables S1-S4 list additional reporter metabolites which are, to our knowledge, not 
(directly) linked with any of the known metabolic players in T2DM. Our analysis nevertheless 
suggests them as potential nodes of disruption or as biomarkers. Measurement of the 
intramyocellular concentration of the reporter metabolites in patients with diabetes risk may help to 
confirm the role of these metabolites in insulin resistance. 
Ph.D. Thesis, Aleksej Zelezniak 
 
79 
Metabolic hubs as reporters  
A particularly interesting finding from our analysis is the identification of highly connected 
metabolites as reporters, including ATP/ADP and NAD+/NADH. We hypothesize that diverse 
environmental and genetic risk factors result in insulin resistance when individuals are unable to 
mediate appropriate compensatory transcriptional and metabolic responses in other parts of the 
network connected by these hubs. Our results also suggest that alterations in gene expression linked 
to the highly connected co-factors are likely to be acquired features of established T2DM. Analysis of 
the transcriptional activity of CREB in the context of ATP concentrations and TCA cycle activity in 
skeletal muscle may help to elucidate regulatory mechanisms leading to these changes. 
Constraints and extension of methodology  
Reconstructed human metabolic network models are still evolving, incomplete, and subject to error. 
Well-annotated pathways such as central carbon metabolism are thereby likely to be over-
represented in the reporter analysis. In order to partially compensate for this limitation, we used two 
reconstructions – Recon1 and EHMN. As network reconstructions will become more complete, it will 
be possible to better assess the extent of this limitation. Another essential input to our algorithm, in 
addition to metabolic network, is gene expression data for the genes represented in the network. We 
would like to note that neither EHMN nor Recon1 network genes were fully represented by the 
microarray chips used in the two case studies. Only 54% and 39% genes from the Recon1 and EHMN, 
respectively, were represented on the chips used in Mexican-American case study, while this 
coverage was 85% and 60% in Swedish case study. Interestingly, re-analysis of the Swedish Male 
dataset by using only a subset of genes from the HG-U133A chip that were represented also on the 
HuGeneFL (used in Mexican-American case study) showed a large overlap between the two reporter 
metabolite sets thus obtained (86% for T2DM vs. NGT comparison and 69% for the rest two). The 
details of this analysis, together with relevant statistical considerations, can be found in 
Supplementary Figure 5.4, Supplementary Table 5.1, Supplementary Table 5.2. 
Although the present analysis identified common metabolic and regulatory signatures across the two 
studies, there are several differences in the study designs, and therefore the results must be 
regarded with certain caution. In addition to relatively low number of subjects in Mexican-American 
study, the differences include fasting state biopsies in Mexican-American study vs. post insulin 
stimulation biopsies in Swedish study. Furthermore, the age and BMI (Body Mass Index) of the 
individuals participating in the two studies were different and may contribute to the differences in 
the observed gene expression patterns. To our knowledge, these two case studies represent the only 
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human skeletal muscle transcriptome datasets that were publically available at the time of here 
reported computational analysis. Analysis of new datasets which may become available in the future 
will be useful in obtaining further insight into molecular physiology of skeletal muscle in the context 
of T2DM. Moreover, emergence of better or new gene expression analysis tools will help to cover 
parts of metabolic network that are currently inaccessible due to the lack of data. 
Extension of the analysis to discover more global regulatory patterns by using additional bio-
molecular interaction data (Oliveira et al, 2008) such as protein-DNA and protein-protein interactions 
will definitely be an important step in obtaining a higher resolution picture of T2DM metabolic 
phenotypes. Availability of such interaction data at the high confidence level of metabolic 
interactions is the current major bottleneck. Another essential extension of the methodology will 
require the use of thermodynamic data for metabolic reactions (Cakir et al, 2006; Henry et al, 2007; 
Kummel et al, 2006). Moreover, since mRNA levels do not necessarily correlate with the protein 
levels, incorporation of the proteomics data together with the thermodynamic data will allow more 
accurate interpretation of the reporter metabolites in terms of implications for flux and 
concentration changes. 
Conclusions  
We demonstrate the use of a network-guided data integration approach to discover key, 
physiologically relevant metabolic and regulatory nodes in T2DM pathogenesis. The methodology 
does not require the use of a priori disease-specific knowledge regarding the involvement of specific 
pathways or metabolites, thereby making it a robust and unbiased analytical framework for studying 
diseases linked to perturbations in the cellular metabolic network. Our results identify the highly 
connected metabolites ATP and NAD as reporters and potential mediators of the widespread 
changes in gene expression linked to insulin resistance in muscle. Moreover, our results extend 
previous knowledge about T2DM pathogenesis at the gene expression level- by reporting additional 
potential sites of disruption, e.g., TCA cycle and Kennedy pathway of phospholipid metabolism. 
Several metabolites from other pathways were also found to display significant differential gene 
expression of the genes around them and we suggest putative regulatory mechanisms behind these 
alterations. Our results suggest a framework of metabolic disruption observed with insulin resistance 
and diabetes, which can be used to test the role of specific pathways in mediating disease 
pathophysiology, and more practically, for the identification of potential biomarkers for preventive 
and therapeutic monitoring.  
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Materials and Methods 
Gene expression and sequence data 
Two datasets used in the study were obtained from the Diabetes Genome Anatomy Project website 
(http://www.diabetesgenome.org). Brief comparison of microarray platforms from the experimental 
studies (Mootha et al, 2003; Patti et al, 2003) used in the current work is presented in the Supporting 
Text 1. Promoter sequences for all genes were obtained from the Ensembl Biomart 
(http://www.ensembl.org/biomart). The transcriptional start sites (TSSs) were identified based on 
the annotation of the Ensembl Biomart sequences. Sequences in the -800 to 200 base pairs region of 
the TSS were deemed as promoter regions for the analysis. Interspersed repeats and low complexity 
DNA sequences were masked out.  
Metabolic networks 
Two reconstructions of human metabolic network, viz., Recon1 (Duarte et al, 2007) and EHMN (Ma 
et al, 2007) were used in this study. The Homo sapiens Recon1 is a comprehensive literature-based 
metabolic network reconstruction that accounts for the functions of 1496 ORFs, 2004 proteins, 2766 
metabolites and 3311 metabolic and transport reactions. The ENMN (Edinburgh Human Metabolic 
Model) is a network reconstructed by integrating genome annotation information from different 
databases and metabolic reaction information from the literature. The network contains nearly 3000 
metabolic reactions, which were reorganized into about 70 human-specific pathways according to 
their functional relationships. The two models mainly differ in the coverage of reactions and in the 
accounting of compartmentalization and inter-organelle transport reactions. 
Significance of differential gene expression 
Preprocessing of the gene expression data was carried out by using the statistical software 
environment – R (www.r-project.org). The probe intensities were obtained and corrected for 
background by using robust multi-array average method (RMA) (Irizarry et al, 2003 2003) with only 
perfect-match (PM) probes. Normalization was performed by using the quantiles algorithm. Gene 
expression values were calculated from the PM probes with the median polish summarization 
method (Irizarry et al, 2003 2003). All data preprocessing methods were used by invoking them 
through the affy package (Gautier et al, 2004) by using rma function. Significance of the differential 
expression was calculated by using the empirical Bayes test (Smyth, 2004). The probe-sets were 
grouped into genes, and to each gene the differential expression was defined by choosing the value 
from the top level probe-set (using the probe-set rank defined by Affymetrix). In case of more than 
one probe-set present at the top level, the median value was used. 
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Reporter metabolites 
Each metabolite in the metabolic network was scored based on the scores of its k neighbor enzymes 
(i.e. enzymes catalyzing reactions involving that metabolite, either as a substrate or as a product). 
Each enzyme was assigned with a P-value for differential expression based on the P-value of the gene 
encoding for that enzyme. In case of isozymes and enzyme-complexes, genes with most significant 
expression change were used to score the enzyme (Figure 5.1). P-values of genes pi, indicating the 
significance of differential expression, were converted to Z-scores Zi by using the inverse normal 
cumulative distribution function (CDF) ( -1):  ii pZ 
 11 . All metabolite nodes were assigned a 
Z-score, Zmetabolite, calculated as aggregated Z scores of the k neighbor enzymes:  
 nimetabolite Z
k
Z
1
. Zmetabolite scores were then corrected for the background distribution by 
subtracting the mean (μk) and dividing by the standard deviation (σk) of the aggregated Z scores 
derived by sampling 10000 sets of k enzymes from the network: 
 
k
kmetabolitecorrected
metabolite
Z
Z


 . 
Corrected Z-scores were then transformed to P-values by using CDF. Metabolites with P-values less 
than 0.05 were deemed as reporter metabolites. Detailed information on the reporter scoring can be 
found in the Supporting Text 1 and (Patil & Nielsen, 2005). 
Transcription factor binding site enrichment 
For all reporter metabolites, we assessed enrichment of known protein-binding sequence motifs in 
the promoter regions (–800 to 200 base pairs relative to the transcription start site) of the 
corresponding neighbor genes. In order to obtain robust results, we only considered sets consisting 
of at least 5 up- or down-regulated genes. For each reporter metabolite, the sequences of all enzyme 
neighbors were used as the positive sequence set, whereas all other enzymes in the network model 
were used as the negative (background) set. Known motifs were identified by using position 
frequency matrices of all known motifs stored in the TRANSFAC database (Matys et al, 2003). The 
motif enrichment analysis tool ASAP (Marstrand et al, 2008) was used to scan all TRANSFAC motif 
matrices against the positive sequence sets of each reporter metabolite. The negative sequence sets 
were used together with 2nd order background model. A one-tailed Fisher’s exact test was used to 
assess per-sequence over-representation of any known motif, and the threshold used to calculate 
significance for each TRANSFAC matrix was set to 70% of the highest-scoring sequence motif. The q-
value cut-off criteria (Storey & Tibshirani, 2003) was used as a post-data measure of statistical 
significance of all motifs found to be significantly enriched. 
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Supporting Text 1  
From gene expression to reporter metabolites – calculation of reporter metabolite score 
We present a step-by-step procedure for calculation of reporter metabolites. The first step is to 
estimate P-value for the significance of differential expression for all of the genes across two 
phenotypes in question, for example, T2DM vs. NGT. In our analysis we used empirical Bayes test 
(Smyth, 2004) to assess the significance of differentially expressed genes. It is possible to use other 
statistical methods, e.g. t-test or ranksum test. The choice of the method depends on the underlying 
structure of the data and assumptions that can be made. The statistical test assigns a P-value to each 
of the probe sets by taking into account the variation within the groups being compared. A gene is 
usually represented by several probe sets, and in such case a P-value for differentially expressed 
gene is defined by choosing the value from the top probe-set
1
, according to the probe-set ranks 
(probe-set ranks are defined by the manufacturer, see Affymetrix web site- 
http://www.affymetrix.com/). Further, by using inverse normal cumulative distribution function, the 
P-value of each of the probe set (gene) is converted to a standard Z-score with a mean of 0 and a 
variance of 1, thus uniformly distributed P-values are transformed to a normally distributed random 
variable (Supplementary Figure 5.1). 
 
Supplementary Figure 5.1 Conversion of gene P-values to standard Z-score using inverse cumulative function. 
The next step is to use gene Z-scores to assign Z-score to the metabolites. Z-score of a metabolite is 
an average of Z-scores of genes connected to that metabolite in the metabolic model. In order to 
evaluate the significance of metabolite scores, average Z-score of each of the metabolites needs to 
be corrected for the background Z-score distribution2 (Supplementary Figure 5.2).  
                                                          
1
 In case if there are several probe-sets representing the same rank the median P-value is selected 
2
 See main text, materials and methods section for background distribution estimation. 
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Supplementary Figure 5.2 Scoring system based on distribution of means. Here a feature is a metabolite. Illustration 
source: (Oliveira et al, 2008). 
After background correction each metabolite’s Z-score is converted to a P-value by using normal 
cumulative distribution function. Overall procedure including a calculation example is illustrated in 
Supplementary Figure 5.3. Metabolites having significant P-values are termed reporter metabolites – 
metabolites around which the most significant transcriptional changes occur. For readers interested 
in further details on the scoring system, including alternative scoring schemes and background 
distribution, please refer to (Oliveira et al, 2008). 
 
Supplementary Figure 5.3 Scoring system for identification of reporter metabolites. Each metabolite is scored based on the 
scores of the associated enzyme-catalyzed reactions. Each enzyme, in turn, is assigned a score based on median of the P-
values of the probes representing the corresponding gene. In case of a reaction catalyzed by an enzyme complex or a set of 
isozymes, minimum of the P-values of the corresponding enzymes is chosen. Numbers in bold are Z-scores for each 
reaction, the rest of the numbers represent P-values (significance of differential expression). 
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Supplementary Figure 5.4 Comparison of results from reporter metabolite analysis based on two different sets of 
metabolic genes – one being proper subset of the other. In order to assess the effect of relatively low coverage of metabolic 
genes on the HuGeneFL (used in Mexican-American case study), we re-analyzed the Swedish Male dataset by using only a 
subset of genes from the HG-U133A chip that were represented also on the HuGeneFL. The results show large overlap 
between the two reporter metabolite sets thus obtained. The left panel shows Venn diagram illustrating the overlap 
between the two reporter metabolite sets, while the right hand side panel shows the distribution of Z-scores for the two 
metabolic gene sets. P-values shown are results of Student’s t-test comparing the two distributions. In all comparisons, P-
values are very low, implying that the two distributions are distinct. This is one of the contributing factors to the difference 
between the reporter metabolite results, in addition to the fact that the number of neighbors for several metabolites is also 
different for each gene subsets. For mathematical description of the relationship between these two factors and reporter 
score, please see materials and methods section in the main text. 
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Supplementary Table 5.1 Brief comparison of the two experimental studies used for identifying metabolic and regulatory 
signatures of T2DM. 
 Swedish male dataset 
 (Mootha et al, 2003) 
Mexican-American dataset  
(Patti et al, 2003) 
Phenotype NGT IGT T2DM FH- FH+ T2DM 
Ethnicity Caucasian Mexican American 
Subject Number 17 8 18 6 4 5 
Age 66.1 (3.4) 66.4 (1.6) 65.5 (1.8) 38.5 (3.7) 40.8 (2.6) 43.8 (2.1) 
BMI, kg/m2 23.6 (3.4) 27.1 (4.8) 27.3 (4.0) 31.2 (0.8) 28.9 (1.4) 37.4 (5.8) 
Microarray  Affymetrix HG-U133A Affymetrix HuGeneFL 
 
Supplementary Table 5.2 Brief comparison of microarray platforms from experimental studies used for identifying 
metabolic and regulatory signatures of T2DM. 
Microarray platform HG – U133A HuGeneFL (Hu6800) 
Number of genes >14 500 ~6800 
Number of probe sets >22 000 6940 
Recon1 coverage*, %  85% 54% 
EHMN coverage*, % 60% 39% 
*Percentage of genes from the model represented on the microarray chip. 
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“In the animal world we have seen that the vast majority of species live in societies, and that they find 
in association the best arms for the struggle for life: understood, of course, in its wide Darwinian 
sense – not as a struggle for the sheer means of existence, but as a struggle against all natural 
conditions unfavorable to the species. The animal species, in which individual struggle has been 
reduced to its narrowest limits, and the practice of mutual aid has attained the greatest 
development, are invariably the most numerous, the most prosperous, and the most open to further 
progress. The mutual protection which is obtained in this case, the possibility of attaining old age and 
of accumulating experience, the higher intellectual development, and the further growth of sociable 
habits, secure the maintenance of the species, its extension, and its further progressive evolution. The 
unsociable species, on the contrary, are doomed to decay.” 
— Peter Kropotkin, Mutual Aid: A Factor of Evolution, 1902 
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Chapter 6 Co-occurring bacterial communities feature high potential 
for metabolic cooperation 
Abstract* 
Microorganisms in their natural habitat often live within large communities. Properties of the 
individual species within a microbial community as well as interspecies interactions are fundamental 
in determining its collective function and ecological impact. While microbial communities from 
diverse habitats are increasingly being characterized in terms of the constituent member species, our 
knowledge of the interspecies molecular interactions remains largely incomplete. Towards 
addressing this question, we identified 7221 microbial groups, with up to 4 members, which co-occur 
across 1237 metagenomic samples. We then used a multi-species network modeling approach to 
estimate metabolic interaction potential and interspecies dependencies within microbial 
communities. Here we show that microbial communities that co-occur across diverse environments 
have markedly higher potential for metabolic interactions. The co-occurring communities showed a 
higher number of possible mutualistic metabolic exchanges and higher degree of interspecies 
dependency. In comparison, phylogenetic relatedness of the member species and their similarity in 
nutritional requirements were both found to be poor descriptors of co-occurrence, suggesting that 
the potential for cooperation outweighs the risk of resource competition in determining community 
structure. The concept of metabolic interaction potential introduced here has implications for 
understanding and manipulation of the structure and stability of natural as well as synthetic 
microbial communities. 
 
  
                                                          
*
 Manuscript in preparation: Zelezniak A, Andrejev S, Ponomarova O, Patil KR. Co-occurring bacterial 
communities feature high potential for metabolic cooperation 
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While molecular biology of monocultures is studied at a high level of detail, interspecies interactions 
and ecological dependencies that exist in mixed microbial populations remain poorly understood. 
Microbial communities of ecological and medical importance are currently probed mainly for the 
identification of the composing members. The knowledge of interspecies interactions, however, is 
lacking in the case of microbial communities living in their natural habitats, as these are difficult to 
investigate in situ. It is generally believed that nutrient exchanges make up a considerable fraction of 
interspecies interactions in natural microbial communities (Cox et al, 1974; Moller et al, 1998; Phelan 
et al, 2012). Interspecies metabolic interactions can take various forms, such as synthrophy 
(sequential metabolism of degradation products) (Falony et al, 2006; Ze et al, 2012), mutualism 
(Periasamy & Kolenbrander, 2009), commensalism (Rakoff-Nahoum et al, 2004) or resource 
partitioning (Lawrence et al, 2012). Such metabolic exchanges can confer several advantages to the 
community as a whole, for example, more efficient and complete use of available nutrients (Poltak & 
Cooper, 2011), or increased ability to survive under diverse/changing nutrition availability, or higher 
resistance to stressors (Ramsey et al, 2011). The current knowledge on metabolic interactions in 
microbial communities, however, is limited to synthetic communities with two (occasionally three) 
members (Freilich et al, 2011; Miller et al, 2010; Stolyar et al, 2007; Wintermute & Silver, 2010). 
Thus, the question remains open regarding the contribution of metabolic interactions in shaping the 
architecture of natural communities, which consist of from tens to hundreds of species. We address 
this question in two steps. First, we take advantage of the large number of metagenomics studies 
available to estimate groups of microbial species that significantly co-occur in different 
habitats/samples. Co-occurrence of such a microbial community suggests functional relationships 
within the community members. In the second step, we developed a multi-species metabolic 
modeling approach and thereby tested the hypothesis that the observed co-occurrence patterns are 
largely due to interspecies metabolic interactions.  
Darwin originally recognized that phenotypic similarity of species influence their interaction with 
other species and environment in predictable ways (Cavender-Bares et al, 2009). In particular, 
Darwin noted that if closely related species are evolutionary similar, they should share similar 
environmental requirements and thus would be expected to co-occur. On the other hand, closely 
related species should exhibit strong competitive interactions due to their ecological similarity, 
thereby limiting their coexistence. Thus, in present work, we wanted to investigate this paradoxical 
phenomenon on the example of microbial communities. Specifically, we were interested in 
examining the roles of competition and cooperation in co-occurrence of microbial species by 
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comparing their phylogenetic relatedness and their metabolic exchange capacity under austere 
nutritional conditions. 
Results 
Determining co-occurring lineages 
Microbial co-occurrence studies so far have been restricted to two species at a time. Such binary 
associations, although insightful (Chaffron et al, 2010; Freilich et al, 2011), may not fully reflect the 
underlying functional interactions/dependencies, as the latter can be masked by the interactions 
mediated by other species. Consequently, such indirect interactions can hamper the interrogation for 
functional molecular interactions, e.g. metabolite exchange. We therefore started by compiling a list 
of co-occurring communities consisting of up to four species by using Fischer’s exact test, applied to a 
dataset consisting of 2801 metagenomic samples (Methods). While 16S rRNA groupings into 
operational taxonomic units (OTU) provide a reasonably good estimate of phylogenetic diversity 
among samples, they do not carry any information about molecular functions of lineages. To address 
this issue and to directly investigate species co-occurrence patterns in environmental samples, we 
assigned OTU representative sequences (Methods) to its best match 16S rRNA gene from fully 
sequenced bacterial genome. In total, about 11% of all OTUs (OTU defined at 97% sequence identity, 
(Chaffron et al, 2010)) appearing at least 3 times among the sampling sites were mapped to 261 
bacterial genomes given the stringent criteria used for mapping 16S rRNA sequences to the bacterial 
species (Methods). 7221 significantly co-occurring communities (FDR ≤ 0.01) were identified in this 
fashion: 381 pairs, 3322 triplets and 3518 of quadruplets (four members) (Supplementary Table 6.1). 
Co-occurring microbial lineages have similar nutritional requirements 
The recent automated genome-scale metabolic reconstruction pipeline Model SEED (Henry et al, 
2010) allowed us to reconstruct simulation-ready bacterial models for all of the mapped genomes 
(Methods). Although Model SEED provides simulation ready models, reconstructed metabolic 
networks, especially non-curated, are still evolving, incomplete, and potentially subject to error. To 
partially address these problems we made a few manual changes (Methods). For example, some 
reaction reaction’s directions varied among different automatically reconstructed models. To 
overcome such an inconsistency, we used directions of the maximum possible number of reactions 
from 8 manually reconstructed models, which still kept model suitable for simulations (Methods).  
Given that we observed combinations of lineages (communities), which were overrepresented in 
samples spanning different habitats, we hypothesized that co-occurring individuals would tend to 
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have similar nutritional requirements. To corroborate this, we developed a metric which shows for 
any given number of species an overlap of common growth requirements for each individual in a 
given community. In other words, metabolic resource overlap (MOP) represents a similarity of 
species with regards to their resource requirements to produce individual biomasses (Methods). We 
computed metabolic resource overlaps for co-occurring communities and compared them with 
random combinations of species. Indeed, we observed that within co-occurring pairs and 
quadruplets metabolic requirements were significantly more similar than the random communities 
(P-value = 0.004; P-value < 10-7 correspondingly, Wilcoxon rank-sum test), though the observed 
difference in median from the random control was not substantial (Figure 6.1A, Supplementary 
Figure 6.1A).  
 
Figure 6.1 Species metabolic requirements are reflected in evolutionary divergence. A) Species with similar metabolic 
requirements tends to co-occur. Density plot represents distribution of calculated metabolic resource overlaps for co-
occurring quadruplets (red curve), see Supplementary Figure 6.1A for all results. B) Phylogenetically close species have 
more similar metabolic requirements. Red line is least squares linear regression fit C) Average phylogenetic distance is 
significantly smaller in co-occurring communities (4 species communities presented, see Supplementary Figure 6.1B for all 
results). Control was computed by randomly sampling 10000 times combinations of groups consisting 4 members (grey 
curve). Importantly, random sampling was performed only from mapped genome space (261 metabolic reconstructions). 
Dotted lines represent medians of distributions. 
One global, though indirect, metric of functional diversity of a microbial community is the 
phylogenetic diversity of its members. One would expect if two species are evolutionarily very 
similar, they would have had similar needs, and therefore their minimal growth requirements would 
be alike. Evolutionary distance is a complex biological phenomenon which is to a large extent is 
reflected in the DNA sequence diversity; however, it is not very obvious to what extent phylogenetic 
distance reflects the metabolic signal. We compared our estimation of shared metabolic resources 
for 10,000 groups of 4 species to the average phylogenetic distance between species in 
corresponding groups (Figure 6.1B). The observed significant (r = -0.48, P-value < 10-7) correlation 
between phylogenetic distance and metabolic resource overlap metric supports the biological 
validity of metabolic models, and the fact that closely related species tend to have similar metabolic 
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requirements. Subsequently, as we did for metabolic resource overlap, we compared phylogenetic 
distance in co-occurring communities to those of the randomly grouped species. Indeed, we 
observed that phylogenetic distance in the co-occurring pair and quadruplet communities was 
significantly less than the random control (P-value = 0.00007; P -value < 6.24∙10-8 correspondingly, 
Wilcoxon rank-sum test, Figure 6.1C, Supplementary Figure 6.1B). The difference, however, was only 
moderate, and the three-species communities did not show significant difference (P-value = 0.783, 
Wilcoxon rank-sum test, Supplementary Figure 6.1B). Overall, neither metabolic resource overlaps 
nor phylogenetic distances were substantially different from random groups of species. 
Co-occurring bacterial communities feature high potential for metabolite interactions 
Metabolite cross-feeding provides an opportunity for species to compensate for the lack of nutrients 
in the environment (Wintermute & Silver, 2010), and thus can induce fitness of community 
members. In a group, individuals will have the maximum number of interactions under growth 
conditions which are favorable for the whole group but not for each individual. Such a condition 
would be found in minimal media (in terms of number of components presented) and not necessary 
unique one which supports growth of every individual in community (Klitgord & Segre, 2010). 
Therefore, we wanted to assess the impact of living in community from the growth perspective. If we 
imagine a community living without interactions it would require more nutrients to sustain each 
individual’s growth as opposed to cross-feeding community. The difference in minimum number of 
components presented in medium between non-interacting and interacting community 
demonstrates the impact of living in a group (Figure 6.2A).We defined this difference, how many 
fewer components would the community need if it was interacting, as metabolic interaction 
potential (MIP) (Figure 6.2B, Methods). 
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Figure 6.2 Interacting communities potentially require fewer components needed for growth. A) A community without 
interaction minimally needs 4 metabolites from environment to have all growing members (upper part). In contrast, a 
crossfeeding group of species potentially would require only one component to grow (lower part). B) Crossfeeding 
communities have lower minimal growth requirements potentially inducing interaction within community. Each boxplot 
represents a distribution of minimal growth requirements for random group (sampled 1000 times) of species of a given size. 
Random sampling procedure was performed using 1532 metabolic models space. 
Although metabolic resource overlap (MOP) and phylogenetic distance in a few cases demonstrate 
significant trends, neither of them was spectacularly different from random control nor provided a 
clue about nature of interactions (Supplementary Figure 6.1). Thus, we wanted to investigate 
whether metabolic interaction potential could explain observed microbial co-occurrence patterns. In 
contrast to MOP and phylogenetic distance, for all the combinations of co-occurring groups of 
species the metabolic interaction potential showed significant strong signals (P-value = 2.58∙10-5; P-
value < 10-7; P-value < 10-7 respectively for pairs, triplets and quadruplets, Wilcoxon rank-sum test) 
(Figure 6.3A). 
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Figure 6.3 Potential for cooperation outweighs the risk of competition. A) Metabolic interaction potential is substantially 
higher within co-occurring communities (red curves), especially larger difference observed in groups of 4 members (right 
panel). Controls were computed by randomly sampling species combinations of corresponding group sizes 10000 times 
(grey curves). Importantly, random sampling was performed only from mapped genome space (261 metabolic 
reconstructions). B) Spider plot demonstrating the importance of metabolite exchanges in co-occurring communities 
(triplets example). The exchanges of amino acids and carbohydrates are needed more frequently in co-occurring 
communities in contrast to random control. C) Species metabolite coupling scores and metabolic interaction potential is 
higher in co-occurring groups, indicating the importance of cooperation for microbial coexistence. 
Notably, a better signal resolution was observed if we considered higher combinations of species 
(combinations of four in contrast to triplets and pairs) suggesting that metabolic interactions can 
occur in higher order multi-species communities (Figure 6.3A, Supplementary Figure 6.1). To 
corroborate this, we performed simulations by computing metabolic interaction potential for 
randomly chosen species combinations of different sizes from space spanning 1503 bacterial 
metabolic reconstructions representing a majority of currently known bacterial taxa. We observed a 
decaying trend with a peak interaction potential at a community size of 6 species, supporting our 
finding that that metabolic interactions could possibly exist in higher order microbial communities 
(Figure 6.4). 
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Figure 6.4 Metabolic interaction potential as a function of community sizes. On average highest metabolic interaction 
potential is observed within community of 6 species. Each boxplot represent a group of species of a given size randomly 
sampled (1000 times) from 1503 metabolic models space. 
Mutualistic metabolite cross-feeding is prevalent in co-occurring lineages 
To study in depth the mechanism behind metabolic interaction potential, we developed the species 
metabolite coupling analysis (SMETANA) framework which allows estimating all possible metabolic 
interdependencies between species within a community. Under defined environmental conditions 
and given that all species have to have a non-zero growth, method is able to determine whether one 
member’s growth is dependent on (coupled to) another member of the community. Furthermore, 
the methodology can determine metabolites that must be exchanged to have non-zero growth, 
including all possible metabolite alternatives between all individuals in a community (Methods). The 
main difference between this methodology and other approaches (Freilich et al, 2011; Stolyar et al, 
2007; Wintermute & Silver, 2010; Zomorrodi & Maranas, 2012) is that it does not assume any 
community objective function. Current microbial community constraint based steady-state modeling 
approaches rely on the main objective, which is often maximization of growth of the community 
under given constraints (Zomorrodi & Maranas, 2012). However, to our knowledge there is no 
experimental evidence studying multi-species community objectives. Moreover, very recently it was 
shown that species evolved in polycultures in a majority of cases have much slower growth 
phenotypes than species evolved in monocultures in the same environment (Lawrence et al, 2012). 
What is more, SMETANA enumerates all possible metabolic exchanges, in contrast to one-steady-
state-solution approaches (Freilich et al, 2011; Zomorrodi & Maranas, 2012), providing a holistic view 
of interspecies metabolic exchanges. From a practical point of view, our methodology is capable of 
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simulating communities of large sizes (100 species models tested) in computationally affordable 
time, making it unique modeling platform available today. 
The outcome of SMETANA is a score which signifies how important the metabolite interaction is 
between two individuals living in a group of species. For example, in a group of three members, in 
the case if one species needs a certain metabolite for growth and two other species can produce it, 
the interaction through this metabolite between the consumer and producer will be less important, 
than if there was only one member of community which could make this metabolite. A detailed 
explanation of scoring system and mathematical formulation can be found in the Methods section. 
For validation, we applied methodology to assess interactions in a well-characterized three-species 
synthrophic microbial system, and simulations were in agreement with experimental results 
(Supplementary Figure 6.4).  
Given that we observed a strong potential of metabolic interaction in the co-occurring groups of 
species we, next, wanted to investigate whether particular type of interactions (commensal or 
mutualistic) were dominant in co-occurring communities and which of the metabolites were causing 
interactions under minimal medium conditions. The results from metabolite coupling analysis 
(Supplementary Figure 6.1) support our finding that co-occurring species tend to have high 
metabolic interaction potential. Metabolic coupling scores were significantly higher (P-value < 10-7, 
Wilcoxon rank-sum test) in co-occurring communities with twice larger median in comparison to the 
random control suggesting that metabolite exchanges are highly important for bacterial coexistence. 
Moreover, mutualistic interactions were significantly (P-value < 10-7, Hypergeometric test) in co-
occurring lineages, suggesting that co-occurring species potentially can back each other up by 
compensating for the lack of nutrients and thus improving the overall fitness of individuals. 
Qualitative assessment of observed interactions showed that exchanges of amino-acids and 
carbohydrates were observed more frequently (P-value < 10-7, Wilcoxon rank-sum test) in co-
occurring bacterial species than in random combinations (Figure 6.3B). 
Overall, the signals of metabolic interaction potential and metabolic coupling scores were 
substantially higher than differences of phylogenetic distances and metabolite resource overlaps in 
co-occurring communities (Figure 6.3C), signifying the importance of cooperation in microbial 
coexistence. 
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Discussion  
The ecology of microbial communities is shaped by evolution and is reflected in variety of 
phenotypes in diverse microbiota. Because phenotype is the fundamental basis of interactions, and 
phenotypes are often specific to certain taxa, one should expect that the phylogenetic composition 
of a community is partially a product of species interactions. Among the oldest evolutionary 
hypotheses, proposed by Darwin in 1859 in The Origin of Species, the Naturalization hypothesis 
suggests that the conflict of existence is stronger between closely related species. Although 
phylogenetic distance and metabolic resource overlap were highly correlated (r = -0.48,  
P-value < 10-7, Figure 6.1B), and both displayed statistically significant signals in co-occurring 
microbial lineages, neither of them were substantially different from random species combinations 
(Supplementary Figure 6.1). This result suggests that the competition for resources does not play the 
dominant role in the evolution of co-existing microbial species, otherwise we would expect the 
phylogenetic distance in co-occurring bacteria to be substantially larger. On the other hand, our 
proposed measure of species metabolic interaction potential shows remarkable statistically 
significant differences when compared to the random control (Figure 6.3A, Supplementary Figure 
6.1C). Furthermore, under nutritionally minimal conditions, metabolite interactions in communities 
are more important than in random groups, as was indicated by high species metabolic coupling 
scores (Supplementary Figure 6.1D). More importantly, mutualistic interactions were dominant (P-
value < 10-7, Hypergeometric test) in co-occurring lineages, an indication that cooperation by 
metabolite cross-feeding potentially plays an important role in the shaping of microbial communities. 
The analysis of present study is based on distributions of 16S rRNA sequences which were isolated 
from samples across a variety of natural environments. The sequences were grouped according to 
their similarities into operational taxonomic units (Chaffron et al, 2010), and a relatively small part 
(~11%) of the total dataset was mapped to the 16S gene of known sequenced bacterial genomes 
using our stringent criteria (Methods). Additionally, the majority of bacteria which are currently 
characterized and sequenced are mainly studied due to their medical and socio-economic interests. 
As a result, the OTU-to-genome mapping is potentially biased towards a particular group of 
organisms. Another potential source of bias can arise due to the numerous many-OTU-to-one-
genome mappings unavoidably affecting the statistics of co-occurrence testing. To address this 
problem and partially overcome such biases, we removed combinations containing the most 
frequently appearing genomes (top 3 accounting for nearly 52% of all co-occurring quadruplets). The 
resulting trend of metabolic interaction potential in co-occurring lineages remained unchanged 
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(Supplementary Figure 6.2). As for metabolic reconstructions, we critically and carefully addressed 
issues which could potentially arise due to the automatic reconstruction process (Methods). All 
comparisons in this study were contrasted against random combinations of species. However, there 
exists the possibility that some groups of species would never be observed together in the same 
sample. To ensure that observed metabolic signals were capturing actual bacterial co-occurrence 
phenomenon and exclude possible biases that could be arisen due to randomization procedure, 
additionally, we repeated the random control procedure by choosing only combinations of species 
taken from the same samples. The alternative randomization procedure did not affect the overall 
results, signifying the importance of metabolic interactions in microbial co-existence (Supplementary 
Figure 6.3). 
In conclusion, we have shown that metabolic interactions are prominently involved in microbial 
coexistence phenomena. Evolutionarily dissimilar microbial lineages did not form co-occurring 
communities more frequently than random, suggesting that competition is not the main determinant 
of microbial coexistence. A high number of mutualistic interactions in coexisting bacteria indicates 
that cooperation is important for microbial coexistence. Taken as a whole, it seems that the role of 
cooperation outweighs competition for resources in shaping microbial community structure. 
Methods 
Mapping OTU to genomes 
16S rRNA sequence data clustered at 97% sequence identity and defined as operational taxonomic 
unit (OTU) was obtained from (Chaffron et al, 2010). Data represents distribution of OTUs in 
environmental samples, where each OTU representative sequence is mapped to a “sampling event”. 
Each “sampling event” is defined as the unique concatenation of three annotation fields: author, title 
and isolation source. 
To map operational taxonomic units to the fully sequenced genomes, we extracted all 16S rRNA 
genes from Kyoto Encyclopedia of Genes and Genomes (KEGG), using the KEGG API 
(http://www.genome.jp/kegg/soap). We then used BLAST (Altschul et al, 1997) to compare obtained 
genome sequences against OUT representative sequences. The criteria for BLAST search were that at 
least 95% sequence identity and at least 95% of alignment of query sequence had to be matched and 
overlapped. In case if there was more than one 16S rRNA gene in genome, we used the longest 
sequence. Each OTU was mapped only once to a highest-ranking genome (highest bit score), but 
genome could be mapped to many OTUs (Supplementary Table 6.1).  
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Co-occurrence analysis 
We tested co-occurrence significance for all possible pairs, combinations of threes and fours using 
Fisher’s exact test. When testing co-occurrence for more than a pair, we have to consider more than 
one test. For example in case if we want to test whether species ABC are tend to co-occur more often 
than any of them alone, it is necessary to count the sites there BC are present but not A, AC are 
present but not B and AB but not C. Thus per triplet there should be tested 3 contingency tables, for 
combinations of fours correspondingly four. 
To compute a large number of combinations in reasonable time we implemented a procedure which 
uses only possible combinations but not those which do not exist in any sample. For example, it 
would compute all combinations at each sampling site and skipping counting if such combination was 
already counted, thus combination s which do not exist at any sampling site will not be considered 
for counting. P-values obtained from multiple combinations tests were subsequently adjusted for 
false discovery (FDR) rate controlling procedure (Benjamini and Hochberg, 1995) as implemented in R 
Bioconductor (www.r-project.org, www.bioconductor.org) ‘multtest’ package. 
Metabolic reconstructions and modeling 
Using an automated genome-scale metabolic reconstruction pipeline Model SEED API (Henry et al, 
2010) we reconstructed a total of 1503 unique simulation-ready bacterial models. Briefly, as input for 
reconstruction a genome sequence is provided, which is subsequently annotated and numerous 
standardized procedures (Feist et al, 2009) are applied to build simulation ready metabolic network. 
Metabolic model consists of complete set of enzymatic reactions, transport reactions and biomass 
equations, all reactions are represented in a stoichiometric matrix, written as a mass balances 
around metabolites, explained in details (Orth et al, 2010). A convention of representing multi-
species model was borrowed from (Stolyar et al, 2007), except that now we extended it for more 
than two species model. 
To avoid inconsistencies in automatic reconstructions, each model was additionally modified. 
Specifically, we noticed that reaction directions were inconsistent across the reconstructions. To 
compensate for these differences we extracted all irreversible reactions from manually 
reconstructed models (in Model SEED reaction space) and used it as an evidence for direction of 
irreversible reactions. In case if there were inconsistencies in manually reconstructions, we used 
directions which were in more than a half models. We formulated a mixed integer linear optimization 
problem to fix maximal number of irreversible reaction directions, while keeping possibility to 
produce biomass. Furthermore, by examining extracellular transporter reactions, we noticed that in 
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majority of cases models had dipeptides transport reactions but no individual transport for 
corresponding amino acids. Manual inspection of models showed that pathways for degradation of 
these amino acids existed in reconstructions. We concluded that such inconsistency could be an 
artifact of auto completion and gap-filling procedures implemented in automated reconstruction 
pipeline. To address this issue and avoid further false interpretations of results, for each dipeptide 
we also added corresponding two amino acid transporter reactions.  
Metabolic interaction potential 
As defined in main text, metabolic interaction potential is a difference in minimal number of 
components required for growth for a non-interacting community vs. an interacting community. 
Non-interacting community is represented by a multi-species model, except that each specie-
compartment cannot excrete metabolite to a common environment, but metabolites are excreted 
from the multispecies-model. To find minimal number of metabolite to sustain community growth 
we implemented “Search for Minimal Media (SMM) Algorithm” described in (Klitgord & Segre, 2010). 
Metabolic interaction potential is computed using Equation 1. 
n
IM
MIP


    (1) 
Here, MIP is metabolic interaction potential; M is the number of metabolites required for growth of 
non interacting community, correspondingly I is the number of metabolites required to support 
growth of interacting community and n is number of species in community.  
Phylogenetic distance 
Phylogenetic tree for 847 bacterial species using phylogenetic marker genes (Ciccarelli et al, 2006) 
and was kindly provided by Daniel Mende (Peer Bork Lab, EMBL). Phylogenetic distance for more 
than two species was computed as average distance between all combinations of pairs. For species 
which were not present in the tree, a random species was chosen from the same genus. 
Metabolic resource overlap 
To estimate metabolic resource overlap of species within community, we computed minimal media 
for whole non-interacting multi-species model. The obtained minimal media was used to constrain 
multi-species model (same model). Under such constraints we estimated minimal requirements of 
individual community member. Equation 2 was used to compute metabolic resource overlap, 
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where M are minimal growth requirements for individual specie, N is the total number of members in 
community.  
Species metabolic coupling score 
Species metabolic coupling score reflects level of dependency of species A on metabolite m produced 
by species B under minimal media MM and is a product of SCS (Species Coupling Score), MUS 
(Metabolite Uptake Score) and MPS (Metabolite Production Score) scores which are explained later.  
                    
SMETANA score is distributed between 0 and 1 where values closer to zero reflect marginal 
dependency of species A on metabolite m produced by species B. On the other hand, scores closer to 
1 denote more important links. As for boundary conditions SMETANA score of 0 means no 
relationship at all while SMETANA score of 1 means an essential dependency.  
Species Coupling Score 
Species Coupling Score (SCS) is a measure of dependence of species A on species B in community C. It 
is a fraction of cases where species A relies on products of donor B in direct or indirect manner over 
all cases. Implementation of SCS involves iteratively solving mixed integer linear programming 
problem, finding minimal set of donor species essential to support growth of species A in community 
C. Each time such set is found it is saved and a constraint eliminating it from further solution space is 
added to the program. The loop is repeated until there are no more such sets to be found. 
Sc_scores = {} 
for A in C: 
  solutions = [] 
  do: 
    species_set = minimize_donors_set(A, C, solutions) 
    solutions += species_set 
  while species_set !=   
  for B in C: 
    if A != B: 
      sc_scores[(A, B)] = len([solutions containing B])/len(solutions) 
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As mentioned before minimize_donors_set routine solves mixed integer linear programming 
problem where objective is to minimize number of donating species in community C (1) while 
retaining growth of species A (4) and satisfying steady-state assumption (2). Other constraints 
include known or assumed flux bounds (3) and constraints controlling on/off state of other species in 
community (5,6). Later works by introducing binary variables s (5). When s is equal to 0 sum of all 
secretion fluxes is equal to 0. In other words, all secretion reactions are blocked in such case. 
Additionally, a constraint ensuring enabled species biomass production is added (6). Finally, to 
enumerate all possible solutions, each time a new solution is found a constraint blocking it from 
further search space is added (7). 
                  (1) 
            
             (2) 
          (3) 
           (4)  
                                            (5) 
                                            (6) 
                                            (7) 
  uptakevituptakevitmeasureduptakevit vvv ... *  
Metabolite Uptake Score 
Metabolite Uptake Score (MUS) is a measure representing the extent to which species A relies on 
receiving metabolite m from other community members. In essence MUS is a fraction of minimal sets 
of received metabolites where metabolite m is present over all other minimal received sets. To 
calculate MUS first all alternative minimal sets of received metabolites for species A are found 
iteratively. Then a fraction of sets where metabolite m appears over all sets is calculated. This routine 
is repeated for each species in community C. 
mu_scores = {} 
for A in C: 
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  solutions = [] 
  do: 
    metabolites_set = minimize_received_metabolites_set(A, C, solutions) 
    solutions += metabolites_set 
  while metabolites_set !=   
  for m in A.received_metabolites: 
    mu_scores[(A, m)] = len([solutions containing m])/len(solutions) 
 
To find a minimal set of received metabolites minimize_received_metabolites_set routine 
solves mixed integer linear programming problem where objective is to minimize number active 
uptake reactions associated with received metabolites (1) while ensuring growth of species A (4) and 
satisfying steady-state assumption (2). Other constraints include known or assumed flux bounds (3) 
and constraints controlling on/off state of uptake fluxes (5). To enumerate all possible solutions, each 
time a new solution is found a constraint blocking it from further search space is added (6). 
Minimize 

 }A from { smetabolitem
m
 (1) 
subject to: 
CsvS ss       ,0  (2) 
uplb vvv    (3) 
1, growthAV   (4) 
} from uptakes smetabolite{       ,0* Amv mm    (5) 
}solutions found previously{        , 

LL
Lm
m
  (6) 
  uptakevituptakevitmeasureduptakevit vvv ... *  
Metabolite Production Score 
Metabolite Production Score (MPS) is a binary value showing whether species B can produce 
metabolite m under given MM. 
mp_scores = {} 
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for B in C: 
  for m in {metabolites produced by B} 
    mp_scores[(B, m)] = maximize_metabolite_yield(m, C) >= 1 
 
To check whether species B can produce metabolite m in community C we iteratively solve linear 
program (maximize_metabolite_yield) where we try to maximize flux of secretion reaction of 
metabolite m in species B (1). As with other routines we assume steady-state of each organism 
separately (2) and constrain values of measured fluxes (3).  
Maximize 

 }A from { smetabolitem
mv
 (1) 
subject to: 
CsvS ss       ,0  (2) 
uplb vvv    (3) 
  uptakevituptakevitmeasureduptakevit vvv ... *  
Removing SEED model artifacts 
While performing simulations we noticed that some organisms were growing by relying solely on 
vitamins which we attributed to the nature of automatic reconstruction of SEED models. We 
addressed this issue by introducing a blacklist of compounds whose use would be limited to their 
primary functions. Specifically, we calculated minimal uptakes of these compounds such that it would 
not damage organism growth. Having these minimal uptakes we added a constraints to all our 
routines ensuring selected compounds would be used only at their minimal rates (  =0.01) 
  uptakevituptakevitmeasureduptakevit vvv ... *  
Statistical analysis 
Pearson correlation coefficients and P-values for null hypothesis of no correlation (regression slope = 
0) between average phylogenetic distance, metabolite resource overlap and metabolic interaction 
potential were calculated using statistical software R (www.r-project.org). For distribution 
comparisons we used Wilcoxon rank-sum test. Random distributions were generated by randomly 
choosing 10,000 times combinations of pairs, triplets and quadruplets from mapped genome space.
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Supplementary Table 6.1 Summary of identified communities and statistics of mappings. 
Number of OTUs with 97% sequence identity 5006 
   
Number of OTUs mapped with 95% sequence identity 
and 95% appearing at least 3 times among samples 
536 
   
Number of mapped genomes 261 
   
Number sampling sites in which mapped genomes were 
present 
1297 
   
 
pairs triplets quadruplets total 
Co-occurring groups identified, FDR ≤ 0.01 381 3322 3518 7221 
Number of possible communities observed in samples 2379 21570 77664 101613 
Unique number of genomes/OTUs observed in significant 
pairs, FDR ≤ 0.01 
127 129 49 150 
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Supplementary Figure 6.1 Summary of all results comparing all metrics calculated in present study. Neither metabolic resource 
overlap (A) nor phylogenetic distances (B) in co-occurring communities were substantially different from random control. In 
contrast, both cooperation measures (C, D) show remarkable differences comparing to the random controls. Controls were 
computed by randomly sampling 10000 times species combinations of corresponding group sizes (grey curves). Importantly, 
random sampling was performed only from mapped genome space (261 metabolic reconstructions). 
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Supplementary Figure 6.2 Sensitivity analysis of results for metabolic interaction potential. After removal of top 3 species (A) found 
in 52% of all identified communities of 4 members, result remained unchanged (B). Results were valid for all co-occurring 
communities (data not shown). 
 
Supplementary Figure 6.3 Summary of all results comparing all metrics calculated in present study using alternative random 
control. A) Alternative random control procedure did not change overall trend of metabolic interaction potential in co-occurring 
communities. Controls were computed by randomly sampling 10000 times (or all possible combinations) species combinations of 
corresponding group sizes (grey curves) only if species were present in the same habitat. Importantly, random sampling was 
performed only from mapped genome space (261 metabolic reconstructions). Neither metabolic resource overlap (B) nor 
phylogenetic distances (C) in co-occurring communities were substantially different from random control.  
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Supplementary Figure 6.4 Experimentally determined interspecies interactions (A) are in agreement with SMETANA predicted 
interactions. Our proposed method identified more possible interactions needed for three-species growth (B). Panel A adopted 
from (Miller et al, 2010). 
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Chapter 7  
Conclusions and Future perspectives 
The work presented in this thesis dealt with the development of methodologies and tools for 
understanding the principles behind the regulation and operation of metabolic networks. Emergent 
regulation of metabolic networks is one of the key messages of the presented work. It appears that a 
majority of metabolites in Saccharomyces cerevisiae at the transcriptional level are regulated in an 
organized manner by balancing the expression of neighboring enzymes. The principles described in 
Chapter 3, Chapter 4 are solely dependent on network topology and possibly can be used to study 
transcriptional regulation in other organisms, including humans. The presented findings can be 
potentially applied to understand the pathogenesis of diseases in terms of perturbed metabolic 
phenotypes in conditions/diseases such as obesity, type 2 diabetes, cancer and many more. In 
particular, a straightforward application would be comparing regulation patterns in a healthy 
population and individuals with disease phenotypes. Hypothetically one would expect that regulation 
around certain metabolite nodes would change in a disease state. For example, co-regulation would 
become prevalent to specific pathways; consequently, one could stratify regulatory programs 
common to disease phenotypes or to certain population groups. Another possible application is to 
understand a short-term evolutionary adaptation of engineered strains. For instance, a common 
practice after performing strain genetic modifications is to make an adaptation experiment for the 
cell to adjust its metabolic phenotype to a more thermodynamically favorable state. Often this 
happens by means of genetic alterations or other unknown factors. I believe that such an adaptation 
leads to global changes of transcriptional regulation. If we would be able to understand how this 
phenomenon happens exactly, perhaps, in the future, we would be able to design and control strain 
adaptation without performing long-lasting experiments. 
Another key finding presented in this work is that co-existing species have greater potential for 
metabolic cooperation than random control. Whether the observed trends of metabolic signal imply 
the causality (or at least degree) of microbial coexistence remains to be determined (if possible), 
nevertheless, the presented results suggest the importance of metabolic interactions in microbial 
coexistence. The work yielded the new tool (termed species metabolic coupling analysis) for 
modeling metabolic interactions and species interdependencies within microbial communities. The 
important feature of SMETANA is that it does not (and does not need to) assume any community 
objectives, making it unbiased and purely dependent on metabolic network stoichiometry. A 
straightforward application of the proposed methodology would be a design of artificial microbial 
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cultures for biodegradation purposes. For example, one might expect to observe steadiness/stability 
of communities if they were metabolically interdependent. Thus, under such constraints it is possible 
to design species combinations which could effectively degrade products of interest while keeping 
interaction among themselves. Furthermore, the species metabolic analysis has potential 
applications for elucidating host-pathogen interactions. It is known that some pathogens occupy 
certain body parts/organs of the human body. Determining pathogen dependencies on the host 
could potentially lead to discovery of novel drug targets. 
The overall objectives of this thesis were to provide insights and develop methods for understanding 
operating principles of metabolic networks in microbial systems. Biological systems are very complex 
by their nature and achieving a complete, quantitative, and predictive understanding of system 
requires a close bridging between mathematical sciences and biology. One PhD project will not be 
able to answer all the questions, but I believe that the presented work brings the field one step 
towards understanding the operation of metabolism. As for me personally, the present work is just a 
beginning for future work directions. 
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